{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "365aa9ad",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "my medibot\n"
     ]
    }
   ],
   "source": [
    "print(\"my medibot\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "8952fb2c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\Manodya\\\\Desktop\\\\Bsc.AI\\\\PROJECTS\\\\Medical chatbot\\\\Medical-chat-bot\\\\research'"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "609796bb",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "os.chdir(\"../\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "fc5ebd96",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\Manodya\\\\Desktop\\\\Bsc.AI\\\\PROJECTS\\\\Medical chatbot\\\\Medical-chat-bot'"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "8111fa36",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "from langchain.document_loaders import PyPDFLoader,DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ca8b7d54",
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'PyMuPDFLoader' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mNameError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[31]\u001b[39m\u001b[32m, line 9\u001b[39m\n\u001b[32m      6\u001b[39m     texts = text_splitter.split_documents(documents)  \u001b[38;5;66;03m# Split the documents\u001b[39;00m\n\u001b[32m      7\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m texts  \u001b[38;5;66;03m# Return the split texts\u001b[39;00m\n\u001b[32m----> \u001b[39m\u001b[32m9\u001b[39m extracted_data=\u001b[43mload_and_split_data\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     10\u001b[39m extracted_data \u001b[38;5;66;03m# Display the first chunk of extracted data\u001b[39;00m\n",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[31]\u001b[39m\u001b[32m, line 3\u001b[39m, in \u001b[36mload_and_split_data\u001b[39m\u001b[34m(pdf_path)\u001b[39m\n\u001b[32m      2\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mload_and_split_data\u001b[39m(pdf_path):\n\u001b[32m----> \u001b[39m\u001b[32m3\u001b[39m     loader = \u001b[43mPyMuPDFLoader\u001b[49m(pdf_path)\n\u001b[32m      4\u001b[39m     documents = loader.load()  \u001b[38;5;66;03m# Fixed method name to lowercase\u001b[39;00m\n\u001b[32m      5\u001b[39m     text_splitter = RecursiveCharacterTextSplitter(chunk_size=\u001b[32m1000\u001b[39m, chunk_overlap=\u001b[32m200\u001b[39m)\n",
      "\u001b[31mNameError\u001b[39m: name 'PyMuPDFLoader' is not defined"
     ]
    }
   ],
   "source": [
    "pdf_path=\"data/3-Lecture-Common-Skin-Disease-2019.pdf\"  # Removed leading slash for Windows compatibility\n",
    "def load_and_split_data(pdf_path):\n",
    "    loader = PyPDFLoader(pdf_path)\n",
    "    documents = loader.load()  # Fixed method name to lowercase\n",
    "    text_splitter = RecursiveCharacterTextSplitter(chunk_size=1000, chunk_overlap=200)\n",
    "    texts = text_splitter.split_documents(documents)  # Split the documents\n",
    "    return texts  # Return the split texts\n",
    "\n",
    "extracted_data=load_and_split_data(pdf_path)\n",
    "extracted_data # Display the first chunk of extracted data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "de855fa3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "119\n"
     ]
    }
   ],
   "source": [
    "print(len(extracted_data))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "266c3dc4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List \n",
    "from langchain.schema import    Document\n",
    "\n",
    "def filter_to_minimal_chunk(extrac)->List[Document]:\n",
    "    minimal_docs:List[Document]=[]\n",
    "    for doc in extracted_data:\n",
    "        minimal_docs.append(\n",
    "            Document(\n",
    "                page_content=doc.page_content,\n",
    "                metadata={\"source\":doc.metadata.get(\"source\")}\n",
    "                )\n",
    "            \n",
    "            )\n",
    "    return minimal_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9cb66c29",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "typing._GenericAlias"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(List[Document])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c3071b25",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Common Skin Disease\\nSurangkana Veeranawin, MD\\nMSc, Queen Mary University of London\\nMmed, University of Sydney\\nDipDerm RCPS(Glas.)\\nDiplomate American Broad of Aesthetic Medicine (ABAM)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4Inflammatory disorder of pilosebaceous follicle with a 90% \\nprevalence in adolescence and young adulthood.\\n\\uf0a4History: often asymptomatic lesions (especially comedone), \\nalthough can be tender (nodules)\\n\\uf0a4Physical: two types of lesions, predominantly affect face, \\nneck, chest and back\\n- Noninflammatory; open(“black head”) and closed (“white \\nhead”) comedones\\n- Inflammatory; papules, pustule, cysts, nodule: deep lesions \\n(leave scars)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4\\n4 Major components\\n•\\nAbnormal follicular keratinization: follicular wall cells fail to \\ndesquamate to the surface in the normal manner.\\n•\\nSebum over production secondary to androgen\\n•\\nPropionibacterium acnes infection; they grow in the \\nsebum-cell mixture.\\n\\uf0a7\\nInflammation\\n\\uf0a4Other components; genetic factors, occlusive cosmetic \\nagents, medication (steroids, ACTH, androgens, lithium, \\nantiepileptics, oral contraceptives), diseases (PCOS, \\nCongenital Adrenal Hyperplasia)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nTreatment Strategies\\n- Retinoid for clearing pores and comedones for all acne \\nconditions\\n- Small inflammatory lesions \\uf0e0Topical Benzoyl Peroxide (BP) &  \\nTopical Antibiotic\\n- Large inflammatory lesions \\uf0e0Oral antibiotic'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nMild \\uf0e8\\uf0e8Topical Only\\n\\uf0a4Decrease follicular plugging\\n•\\nRetinoid \\n•\\nNightly\\n•\\nAdapalene (Differin); if can not tolerate retinoid\\n•\\nSalycilic acid wash/scrub\\n\\uf0a4Decrease P. Acne\\n•\\nTopical Antibiotic \\n•\\nClindamycin  \\n•\\nBenzoyl peroxide; bacterialcidal, decrease sebum/oil'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nModerate or nonresponsive to topical\\n\\uf0a4Add oral antibiotic\\n•\\nTetracycline\\n250 – 500 mg twice/day\\n•\\nMinocycline \\n50 – 100 mg twice/day\\n•\\nDoxycycline\\n50 – 100 mg twice/day\\n\\uf0a4Add chemical peel  \\uf0e0Salicylic or Jessner'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\n\\uf0a4Other treatment\\n- comedone extraction, intralesional cortisone injection (for \\npapulonodules, cysts), oral contraceptives (esp. anti-\\nandrogenic such as cyproterone acetate), photodynamic \\ntherapy, spironolactone (reduces androgen production; 50 \\n– 200 mg/day), dermabrasion\\n- Patients should be forewarned of acne exacerbations in \\nthe first month of systemic therapy as deep-seated acne \\ncomes to the surface. Also, systemic therapy can required 6 \\nwk before benefits are noted'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Chronic vascular & acneiform disorder\\n\\uf0a4Common chronic inflammatory disorder of pilosebaceous units \\nand vasculature of the face\\n\\uf0a4Role of Demodex mite controversial\\n\\uf0a4Increase reactivity of capillaries \\uf0e8\\uf0e8\\uf0e8Flushing\\uf0e8\\uf0e8\\uf0e8ultimately \\nleading to telangiectasia'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Easy and recurrent flushing\\n\\uf0a4Sensitive skin\\n\\uf0a4More common in fair skin\\n\\uf0a4May complain of dry and gritty eyes\\n\\uf0a4Female > male\\n\\uf0a4Peak incidence 30-50 yr'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\nEXACEBATE BY\\n\\uf0a4Heat,rapid change in temperature\\n\\uf0a4Sun exposure\\n\\uf0a4Cold\\n\\uf0a4EtOh\\n\\uf0a4Stress\\n\\uf0a4Spicy food\\n\\uf0a4Hot food/beverage\\n\\uf0a4Caffeine'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4Clinical appearance: Erythema, telangiectases, papules, \\nand pustules of central face; no comedones in contrast \\nto acne.\\n\\uf0a4Erythema of the nose is highly characteristic of rosacea\\n\\uf0a4Accompany with, sebaceous hyperplasia, seborrheic\\ndermatits & facial lymphedema more common'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Predominantly central face\\n- Forehead\\n- Cheeks\\n- Nose\\n- Chin\\n- Occasionally eyelids'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a44 Major subtypes\\n\\uf0a4Vascular rosacea ( Erythematotelangiectatic rosacea)\\n\\uf0a4Papulopustular rosacea\\n\\uf0a4Ocular rosacea: gritty, conjunctival injection, styes and \\nphotophobia. (The eye is involved in about 50% of cases)\\n\\uf0a4Nasal sebaceous hyperplasia (rhinophyma): chronic \\ninflammation may progress to rhinophyma (more common in \\nmale)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA\\nRHINOPHYMA\\nPAPULOPUSTULAR'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Investigation\\n- Clinical diagnosis\\n- Skin biopsy to rule out lupus or sacoidosis\\n\\uf0a4Differential Diagnosis\\n- Acne              - Lupus erythematosus\\n- Sarcoidosis\\n- Seborrheic dermatitis     - Perioral dermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf07d\\nManagement\\n- Based on severity and  subtype.\\n- Lifestyle modification : Avoid triggers ; sun protection & \\navoidance.\\n- Topical antibiotic \\n\\uf096\\nMetronidazole 0.75% gel or 1% cream bid\\n\\uf096\\nSodium sulfacetamide lotion 10% bid\\n\\uf096\\nAzelaic acid QD'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n-\\nOral antibiotic (moderate to severe cases with \\ninflammatory papulopaustular component)\\n\\uf096\\nTetracycline 500 mg po BID\\n\\uf096\\nMinocycline 100 mg OD – BID\\n\\uf096\\nDoxycyline 20 mg po bid (subantimicrobial dose \\ntherapy) or 100 mg po qd-bid\\n- Isotretinoin and prednisolone for very severe cases'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n- Light therapy\\n\\uf096\\nTreatment of Choice \\uf0e0IPL (400nm – 1200nm), PDL  \\n(595 nm) for telangiectases\\n\\uf096\\nAblative laser (CO2) for rhinophyma\\n- Ophthalmologist to assess for ocular involvement \\n(blepharitis, conjunctivitis)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Acute, self-limited papulosquamous inflammatory skin \\nexanthem in 15-40 yr.\\n\\uf0a4The primary lesion is an oval, salmon-colored, 1-10 cm \\nplaque that forms a round collarette of scale in the \\ncenter.\\n\\uf0a4It evolves rapidly, usually beginning with patch that \\nheralds the eruption, the so-called “herald patch.\\n\\uf0a4Clinical appearance: Scaly pink-erythematous plaques; \\npredominantly trunk affected, in “Christmas-tree” pattern'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Etiology: Possibly triggered by human herpes virus 7\\n\\uf0a4History: May be pruritic or asymptomatic; preceding URTI or \\nmild constitutional symptoms\\n\\uf0a4Lesions are found on the trunk and usually spare the face \\nand extremities\\n\\uf0a4The number of lesions is highly variable. Plaques may extend \\nto the neck and proximal limbs\\n\\uf0a4Numerous lesions may appear. A concentration of lesions on \\nthe groin and lower abdomen is highly characteristic, \\nespecially in children'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Course: Self-resolving in 6-8 weeks\\n\\uf0a4Investigations: Clinical; scraping for KOH (R/O tinea) or \\norder RPR (R/O syphilis), or skin biopsy if uncertain.\\n\\uf0a4DDx: Eczema, psoriasis, tinea corporis, syphilis, seborrheic\\ndermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Management\\n- Reassurance is key\\n- Symptomatic management of pruritus (e.g. mild topical \\nsteroids, antihistamines); mentholated lotion or sprays for \\nitching\\n- Erythromycin 250 mg, q.i.d or 25-40 mg/kg in four divided \\ndoses in children for 2 weeks may clear the eruption\\n- Light therapy (e.g. UVB) may help hasten resolution and \\nrelieve pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4Acute or chronic inflammatory disorder affecting the skin, \\nscalp hair follicles, mucous membranes, and nails (5%-\\n10%)\\n\\uf0a4Etiology: Likely an immunologically mediated reaction; \\noral erosive lichen planus associated with hepatitis C \\n(Characteristic eruption of unknown etiology)\\n\\uf0a4History: Uncommon in children. Family history is 10%. \\nPruritus common; oral lesions may or may not be \\nsymptomatic. Ask about Hep C risk factors (e.g., \\ntransfusions) for oral erosive LP. May be drug-induced.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4Physical: 7 P’s\\n- Planar (flat-topped)        - Pruritic (intense)\\n- Purple                                - Polygonal\\n- Papules                             - Penile (commonly affected)\\n- Prolonged course (up to 18 mo; longer in some case)\\n\\uf0a4Distributed on flexor surfaces, penis (glans), mouth (lacy white \\npatches or erosions – Wickham striae)\\n\\uf0a4Koebner phenomenon: appearance of lesions at sites of trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4Course: May resolve spontaneously or have chronic \\ncourse (esp. oral LP); increase risk of oral SCC in oral LP\\n\\uf0a4DDx: Drug reaction, Pityriasis rosea, Psoriasis\\n\\uf0a4Investigations: Skin biopsy if unsure of diagnosis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4\\nManagement\\n\\uf0a4\\nTopical: Mild to high potency steroid bid for 2 weeks; intralesional if \\nhypertrophic/thick. Triamcinolone acetonide in adhesive base for oral lesion\\n\\uf0a4\\nSystemic: (if severe and generalized)\\n-\\nPrednisolone; a 4 weeks course starting at 1 mg/kg q.d. \\n-\\nRetinoids\\n-\\nUV therapy\\n-\\nCyclosporine\\n-\\nMetronidazole 500 mg po bid * 6 wk, sedative antihistamines for itching'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Common (1%-2% prevalence), chronic, recurrent \\ninflammatory skin disease with unpredictable course.\\n\\uf0a4Onset: any age, peaks late twenties\\n\\uf0a4Etiology: Genetic & environment factors; abnormal \\nepidermal differentiation and hyperproliferation initiated \\nand maintained primarily by T-cell\\n\\uf0a4History: Visible itchy red plaques with increase skin scaling \\nand peeling. May have joint pain (7-20%). May have \\npreceding URTI (Streptococcus infection). Worsened by \\nsmoking, alcohol & stress, physical trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Physical: Most common chronic plaque psoriasis. \\nCharacteristic sharply defined, erythematous plaques \\nwith silvery-white scale; distributed over extensor surfaces \\n(elbows, knees), scalp, sacrum and other sites\\n-\\nNail psoriasis: Pitting, thickening, “oil-drop”, lifting of nail \\nplate off of distal nail bed (onycholysis)\\n-\\nKoebnerization = new lesions occur at sites of skin trauma \\n(as with lichen planus)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Variants: Vulgaris, palmoplantar, guttate (may follow \\nstreptococcal pharyngitis), erythrodermic, pustular, \\ninverse (affects folds and flexor surfaces)\\n\\uf0a4Drug may precipitate or exacerbate psoriasis: \\nAntimalarials, clonidine, indomethacin, iodine, lithium, \\nNSAIDS, quinidine, some beta-blockers, steoids\\nwithdrawal and terfenadine.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Plaques type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Erythroderma)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Guttate type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Palmoplantar)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Inverse type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4In 10-20% may be associated with psoriatic arthritis, most \\ncommonly of the small joints of the hands and feet; \\nrequires systemic Tx\\n\\uf0a4Investigation: Clinical diagnosis; skin biopsy if uncertain\\n\\uf0a4DDx: Drug reaction, eczema. Lichen planus, pityriasis\\nrubra pilaris'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Topical\\n- Steroids; Fast, temporary relief (atrophy, telangiectasia)\\n-\\nCalcipotriol ointment, 100g bid. on weekdays as \\ntolerated + topical steroid bid., weekends\\n-\\nTazarotene 0.05%, 0.1% cream qhs\\n-\\nTar preparations; low cost, effective (limited by odor, \\nirritation, clothing stains)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Systemic\\n-\\nMethotrexate; Folic acid antagonist that inhibits DNA \\nsynthesis & causes immunosuppression (Bone marrow and \\nhepatic toxicity, nausea, anorexia, fatique, oral ulceration)\\n-\\nCyclosporine; Immunosuppressant that inhibits IL-2 \\nproduction & thus reduces T-cell proliferation (Renal toxicity, \\nhypertension)\\n-\\nAcitretin; Inhibits cell replication by modulating cellular \\ndifferentiation within the epidermis. May combine with PUVA \\nor UVB.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Phototherapy\\n-\\nUVB (narrowband ultraviolet B); administer 2-5 times per \\nweek.\\nor\\n- PUVA; Interferes (Psoralen plus ultravioletA) with DNA \\nsynthesis, decreases cellular proliferation, and induces \\napoptosis of cutaneous lymphocytes leading to localized \\nimmunosuppression. Administer 3 times per week until clear, \\nthen tapered. (Skin cancer development, photoaging)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Newer Biological Agents\\n-\\nAlefacept ; Fusion protein of Fc receptor of human lgG1 and LFA3. (IM; \\nwhen effective long remissions; monitoring of CD4 q wk; slow onset)\\n-\\nEfalizumab ; Humanized monoclonal antibody to CD11 a; blocks LFA-1/ \\nICAM interaction. (SC; rapidly effective, but rebound; risk of \\nthrombocytopenia)\\n-\\nEtanercept ; Fusion protein directed against soluble TNFa(SC; effective for \\npsoriasis & psoriatic arthritis; rapid onset; no monitoring; use +/- MTX)\\n-\\nInfliximab ; Chimeric monoclonal antibody against TNFa (IV; Fast onset and \\nvery effective; must do PPD; infusion reactions.\\n-\\nAdalimumab ; Fully humanized anti-TNF monoclonal antibody (SC; newest \\nof the biologics, still being studied.\\nNote TNF drugs avoid or use with caution in presence of CHF, demyelination \\ndisorders. Increased risk of opportunistic infections.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Scalp; 10% salicylic acid in mineral oil qhs, tar shampoo \\nqd, steroid lotion, calcipotriol lotion.\\n\\uf0a4Nails; Intradermal triamcinolone acetonide injections \\n(painful), methotrexate, new biologics.\\n\\uf0a4Generalized psoriasis (>10% BSA) benefits from systemic \\ntherapy, best administered by an experienced physician'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4Acquired skin disorder characterized by well-defined \\nareas of complete epidermal depigmentation; various \\npathogenesis theories; likely a large autoimmune \\ncomponent\\n\\uf0a4History; Asymptomatic: 50% present before age 20, 1-2% \\naffected, rare in infancy & old age\\n\\uf0a4Associated with immune disorder; therefore workup for \\nthyroid disease, diabetes, pernicious anemia and other \\nautoimmune diseases occasionally indicated'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4Physical: Stark white patch with well-demarcated border; \\nhair in vitiligo patches appears white or gray\\n\\uf0a4Increased risk of sunburn and skin cancer in amelanotic\\nareas\\n\\uf0a4Investigations; Wood’s lamp accentuates areas of vitiligo\\n& helps determine extent; consider TSH and fasting blood \\nglucose\\n\\uf0a4DDx; Leprosy, pityriasis alba, tinea vesicolor, tuberous \\nsclerosis, nevus depigmentosus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4\\nManagement\\n-\\nMainly for cosmetic, psychological burden\\n-\\nTopical steroids and new topical immunomodulators (tacrolimus & pimecrolimus), \\nPUVA, NB-UVB, phototherapy\\n-\\nCamouflage makeup\\n-\\nNote that facial and more proximal lesions respond better than acral lesions\\n-\\nSurgical transplants can be considered in stable vitiligo\\n-\\nIf extensive, can consider bleaching of nonaffected areas to result in total white \\ncolor\\n-\\n-Advise; importance of sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4Etiology: Self-limited viral infection of skin caused by \\npoxvirus affecting mainly children.\\n\\uf0a4Immunocompromised patients (e.g., HIV) may develop \\nmore widespread and larger lesions\\n\\uf0a4History: Asymptomatic; occasional perilesional pruritus, \\nvery common in children. Spread by direct contact or \\nautoinoculation. Lesions tend to be more numerous and \\nspread rapidly in patients with atopic dermatits.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4Physical: 2- to 6- mm firm, flesh colored, dome-shaped, \\numbilicated pearly papules; most common affected sites –\\ntrunk and face of children, genital/inner thigh of sexually \\nactive adults\\n\\uf0a4Molluscum papules in a child in the periorbital region. \\nLesions can be spread by picking and scratching. Lesions \\nwill be resolve with development of cellular immunity. \\n\\uf0a4Course: lesions typically involute spontaneously within 9-12 \\nmo; may develop adjacent eczema (10%)\\n\\uf0a4Investigation: clinical diagnosis, biopsy if uncertain\\n\\uf0a4DDx: BCC, milia, other infection, warts'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4\\nManagement\\n-\\nObservation\\n-\\nLiquid Nitrogen Cryotherapy\\n-\\nCurettage: may be uncomfortable\\n-\\nPapule incision with a scalpel blades or at home sharp fingernail and expression of \\ncontents\\n-\\nTopical cantharidin 0.7%: Blistering will occur\\n-\\nImiquimod cream, Tretinoin cream\\n-\\nIn children with widespread involvement, may consider oral cimetidine (40 \\nmg/kg/d ) for 2 mo.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4Etiology : Common superficial cutaneous fungal infection \\ncaused by Malassezia furfur (Pityrosporum orbiculare), The \\norganism is part of normal skin\\n\\uf0a4History : May itch but usually asymptomatic, young adults \\ntypically affected (years of higher sebaceous activity) ; \\ncommonly recurs (40-60%) ; more common in hot and humid \\nenvironments.\\n\\uf0a4Cushing disease, pregnancy, mulnutrition, corticosteroid \\ntherapy, immunosuppression, oral contraceptives may lower \\nresistance, allowing this normally non-pathogenic resident \\nyeast to poliferate'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4Physical : Round to oval macules and patches on the \\ntrunk extending to the upper arms, neck, abdomen; \\ndifferent colors: White, orange-brown, dark-brown; very \\nfine scale; postinflammatory hypopigmentation is often \\nnoted rather than initial erythema.\\n\\uf0a4Investigations: KOH test reveals diagnostic “spaghetti & \\nmeatballs” (hyphae & spores); Wood’s lamp shows \\nyellow-brown fluorescence. Skin biopsy if diagnosis \\nuncertain.\\n\\uf0a4DDx : Tinea corporis, vitiligo, psoriasis.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)\\n\\uf0a4Management\\n\\uf0a4Topical or systemic treatment.\\n\\uf0a4Nizoral shampoo (ketoconazole 2%) applied onto dampened \\ntrunk skin, lathered for 5 min before rinsing, x 3 d.\\n\\uf0a4Topical selenium sulfide 2.5% shampoo applied for 15 min x 3 d.\\n\\uf0a4Topical nizoral cream 2% (ketoconazole) bid x 2 wk.\\n\\uf0a4Systemic ketoconazole 200 mg po qd x 5 – 7 d or fluconazole \\n400 mg x 1. Postinflammatory hypopigmentation may persist for \\n6 – 12 mo.\\n\\uf0a4Even with treatment, tendency to recur in summer.\\n\\uf0a4Zinc pyrithione soap lather may be applied to the body 1 – 3 \\ntimes weekly for prevention.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4Dermatophyte digest and invade keratin then infect skin, \\nnails and hair; incubation period = 1-3 weeks\\n\\uf0a4Trychophyton, Microsporum, Epidermophyton species \\ncommonly involved.\\n\\uf0a4Risk Factors; Hot, humid environment, sweating or \\nmaceration of the skin, occlusive footwear, Diabetes \\nmellitus, immunosuppression\\n\\uf0a4History: Asymptomatic; occasionally mild pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4Physical; Scalp hair and general body surfaces mostly \\naffected during childhood; hand, foot or nail infections \\nare more common after puberty\\n\\uf0a4Immunologic response to a dermatophyte infection may \\nresult in a dermatophytid reaction: Vesicular eruption on \\nacral surfaces, especially the palms'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4Investigations; Skin scraping analysis with KOH prep –\\nSeptate hyphae branching at various angles are seen; \\nfungal culture\\n\\uf0a4DDx; Eczema, granuloma annulare, psoriasis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4Caused by invasion of stratum corneum and hair shaft with fungal \\nhyphae.\\n\\uf0a4Four clinical infection patterns;\\n-\\nSeborrheic dermatitis type- Diffuse, patchy scale on scalp\\n-\\nBlack dot pattern- hyphae invade hair shaft. Hair then broke at \\nscalp surface. Broken shaft like black dots. Round area of alopecia \\nwithout inflammation\\n-\\nInflammation tinea capitis (kerion)- Deep boggy round masses with \\npustules, surface exudate\\n-\\nPustular- Pustules areas without scaling, significant hair loss may be \\npresent, look like scalp bacterial infection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic dermatitis type – Tinea\\nCapitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Black dot pattern – Tinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Inflammation tinea capitis (kerion) –\\nTinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4Management\\n-\\nExamine sibling and household members, clean or discard \\ncontaminated objects.\\n-\\nGriseofulvin; usually 6-12 weeks\\n-\\nItraconazole and fluconazole; taken for 4-8 weeks. A single dose of \\n150 mg once weekly for 4 weeks also be effective for older children\\n-\\nShampoo with selenium sulfide 1% or ketoconazole every other day \\nfor the first 2 weeks, then twice weekly throughout course of rest of \\noral therapy. Shampoo is left for 5 min\\n-\\nConsider suppression kerion inflammation with prednisolone 1-2 \\nmg/kg qd or intralesional triamcinolone 10 mg/cc'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4Common form of septal panniculitis that is usually a reactive skin response to \\nan associated trigger\\n-\\nInfections; Bacterial (e.g., streptococcal pharyngitis), microbacterial\\n(tuberculosis)\\n-\\nDrugs; e.g., oral contraceptives, sulfonamides\\n-\\nSarcoidosis\\n-\\nInflammatory bowel disease\\n-\\nBehcet disease\\n-\\nMalignancy\\n-\\n- Pregnency'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4History; Lesions may be associated with fever, malaise, \\nleg edema and arthralgia. Resolution after 2-6 wk\\n\\uf0a4Physical; painful, dull, erythematous nodules 1-5 cm in \\ndiameter, located on anterior lower legs of young \\nwoman. No ulceration, discharge or scarring\\n\\uf0a4Investigation; Through review of systems: CBC, UA, chest \\nx-ray and throat swab\\n\\uf0a4DDx; Insect bite reaction, erysipelas, urticaria'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4Management\\n-\\nInvestigate for and treat underlying cause.\\n-\\nMost patients benefit from bed rest, applying ice or cool \\ncompresses, elevating legs & NSAIDs\\n-\\nLess common Tx choice; Oral prednisolone, colchicine, \\ndapsone'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4An inflammatory condition of degenerative collagen. \\nWhen present, it is often associated with diabetes\\n\\uf0a4Lesions usually develop slowly and are often \\nasymptomatic, onset may occur at any age but the \\ndisease most common starts at 3rd – 4th decade. About \\n75% of those affected are women'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4Physical Findings\\n\\uf0a4Lesion are usually limited to the anterior shins but may be seen \\non calve and thighs, and rarely on the arms, hands, feet and \\nscalp.\\n\\uf0a4They begin as round, violaceous patches and slowly expand. \\nThe advancing border is red, and the central area turns a \\ncharacteristic orange-yellow brown. The central area atrophies \\nand shows a shiny, waxy surface with prominent telangiectasias.\\n\\uf0a4Ulceration may occur, particulary after trauma, in about 15% of \\ncases. These ulcers are exquisitely tender.\\n\\uf0a4The number or severity of lesions or ulcerations has not been \\ncorrelated with the degree of diabetic control.\\n\\uf0a4The course is unpredictable. Lesions usually heal with atrophic \\nscarring, or can be chronic and recurrent.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4Treatment\\n\\uf0a4Topical and intralesional steroids slow the inflammation but may \\npromote further atrophy. Middle- to high-potency \\ncorticosteroids can be used under occlusion.\\n\\uf0a4Intralesional injections of triamcinolone acetonide 10 mg/mL \\ncanbe helpful.\\n\\uf0a4A short course (5-6 weeks) of oral corticosteroids can be \\nconsidered if disease activity and symptoms are severse, but this \\nis rarely the case.\\n\\uf0a4Pentoxifylline (Trental) 400mg t.i.d. has been advocated by \\nsome and has been used in combination with low-dose aspirin \\nfor ulcerating necrobiosis lipoidica. \\n\\uf0a4Skin grafting can be performed for extensive disease.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d\\nCommon idiopathic benign epidermal growth\\n\\uf07d\\nCommon in fourth decade\\n\\uf07d\\nMales and females equally affected\\n\\uf07d\\nMore common in fair skin\\n\\uf07d\\nPossibly autosomal dominant\\n\\uf07d\\nGradual development; occasionally pruritic or sore'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d\\nWell circumscribed  epidermal growth, raised lesions\\n\\uf07d\\nWaxy round-oval papules and plaques with verrucous or \\ncrusted surface. Sharp border\\n\\uf07d\\n“Stuck on” appearance \\n\\uf07d\\nStarts as light brown macule \\nlarger and verrucous with \\ntime\\n\\uf07d\\nAlso, smooth-surfaced lesions contain dark or light round \\nhorn pearls embedded in the lesion or protruding from the \\nsurface. \\n\\uf07d\\nVariably pigmented and size\\n\\uf07d\\nMost commonly: trunk, neck, arms, scalp; wide range of size'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4Leser-Trelat sign: Sudden, eruptive seborrheic keratoses in \\nelderly individuals, often with inflammatory base may be \\na sign of an associated internal (stomach cancer & \\nothers) malignancy as part of paraneoplastic syndrome'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4Investigation: Clinical diagnosis; skin biopsy if uncertain.\\n\\uf0a4DDx: AK, BCC, lentigo, melanoma, nevus, skin tag, wart'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d\\nTreatment may be indicated for symptomatic lesions which \\nare inflamed, irritated or bleeding.\\n\\uf07d\\nTHERAPIES\\n◦\\nCryotherapy; for flat to minimally raised lesions. \\n◦\\nLight cautery/electrodessication \\n◦\\nShave excision\\n◦\\nLaser\\n\\uf096\\nNot effective for thicker lesions \\n\\uf096\\nRuby (694nm)\\n\\uf096\\nAlexandrite (755nm)\\n\\uf096\\nCO2\\n\\uf096\\nErbium'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d\\nMost common precancerous lesions in humans, and more \\nprevalent in fair-skinned individuals who tan poorly and burn \\neasily.\\n\\uf07d\\nFound in sun-exposed skin \\n◦\\nFace, ears\\n◦\\nNeck, forearms\\n◦\\nDorsal hands\\n\\uf07d\\nOutdoor occupations, ionizing radiation, \\nand arsenic exposure'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d\\nCommon in skin type I-III\\n\\uf07d\\nSecondary to cumulative keratinocyte damage\\n\\uf07d\\nAtypical keratinocytes confined to epidermal basal layer\\n\\uf07d\\n< 1% progress to skin cancer (squamous cell carcinoma, SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf0a4Clinical appearance\\n- Slightly erythematous, rough, scaly papules on sun-exposed \\nareas\\n- May be difficult to see, but often feel rough: Palpation is \\nessential to diagnosis.\\n- Most commonly in the elderly\\n- DDx: BCC, Bowen disease, SCC\\n- Investigation: Biopsy if recurrent, unresponsive to treatment, \\nor pronounced hyperkeratosis and induration'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d\\nTreatment options\\n◦\\nTopical\\n\\uf096\\n5%  5-flourouracil  (Carac, Efudex) applied bid for 2-4 \\nwk\\n\\uf096\\n5% Imiquimod (Aldara) applied three to five times \\nweekly for 12 wk\\n\\uf096\\nExpect \\nerythema, irritated, inflamed and crusting; \\nfollow-up visit in 1-2 wk to evaluate severity of side \\neffects'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n◦\\nLiquid Nitrogen Cryotherapy for limited lesions\\n◦\\nElectrodesication and curettage, CO2 laser\\n◦\\nDermabrasion\\n◦\\nChemical peel (for numerous AKs)  \\n\\uf096\\nSerial medium depth \\nTCA\\n◦\\nLight Therapy\\n\\uf096\\nPDT with ALA. Pulsed CO2\\nSun-awareness and protection advice'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Most common cutaneous malignancy derived from stem \\ncells of epidermis. Locally invasive, slow-growing, rarely \\nmetastasizes (unless patients is immunocompromised)\\n\\uf0a4Etiology: Chronic UV exposure (Cumulative sun exposure \\nis primary risk factor), radiation, immunosuppression, \\ngenetics (e.g., nevoid basal cell carcinoma syndrome)\\n\\uf0a4History: Persistent, nonhealing papule or nodule that \\nulcerates or bleeds (beefy-red smooth erosive nodule). \\nCommon in elderly (most common after 40) Caucasians.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Physical: Pearly papule or nodule with telangiectases, \\nrolled border; central crust or ulceration.\\n\\uf0a4Distributed mostly on sun-exposed areas, i.e., head and \\nneck (85%). Variants: Superficial, nodular, sclerosing\\n(morpheaform), pigmented\\n\\uf0a4DDx: Melanoma, nevus, SCC\\n\\uf0a4Investigations: Biopsy must be performed to confirm \\ndiagnosis and classify subtype.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Physical Findings\\n- Nodular BCC: Most common variant. A pearly white, \\nalmost translucent, dome-shaped papule with overlying \\ntelangiectasias. Papule or nodule enlarges slowly, may \\nbecome flattened in center or may develop a raised, rolled, \\ntranslucent border. Frequently ulcerates, bleeds, becomes \\ncrusted in center'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n-\\nPigmented BCC: contains melanin, may therefore \\nresemble melanoma\\n-\\nSuperficial BCC: least aggressive form. More commonly \\non trunk, extremities. Circumscribed, round to oval, red, \\nscaling plaque resembles eczema, psoriasis, \\nextramammary Paget disease or Bowen disease\\n-\\nSclerosing BCC : Most subtle and least common variant. \\nSmooth, pale white to yellow papules. Resembles scar \\ntissue. Borders may be difficult to discern. Higher rate of \\nrecurrence'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nNodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nPigmented BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSuperficial BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSclerosing BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Management\\n- Advise that metastases and death are extremely rare. Vast \\nmajority cause no major problem, but should be treated\\n- Without treatment, BCCs persist, enlarge, ulcerate, invade, \\ndestroy surrounding structures \\n-\\nTx options depend on histological subtype and location: \\nLiquid nitrogen cryotherapy (requires experience), \\ncurettage & electrodessication (most common Tx), excision, \\nMohs micrographic surgery, imiquimod cream for superficial \\nsubtype, 5-FU, CO2 laser, radiation therapy\\n-\\nAdvise on sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Electrosurgery of obvious tumor. The 5 year cure rate \\napproach 92%\\n\\uf0a4Primary excision is preferred for non-facial, well-defined \\nnodular. The 5 year rate approach 90%\\n\\uf0a4Mohs microsurgery is a highly specialized, tissue-sparing \\nmethod of excision used for difficult tumors with \\ncontiguous growth. It is also used for recurrent BCC, \\nhistological  aggressive forms of BCC, such as sclerotic \\nBCCs, and tumors in anatomically important locations \\nsuch as around eyes, nasal alar, mouth and ears.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Radiation therapy may be useful for difficult-to-treat \\ntumors, such as eyelids, and for patients unable to \\ntolerate surgery. The 5 year cure rates are roughly 90%\\n\\uf0a4Photodynamic therapy is an evolving chemotherapeutic \\nmodality for superficial BCC\\n\\uf0a4Topical imiquimod 5% cream is an immune response \\nmodifier shown to be about 85% effective or better for \\nsuperficial BCC. It is less effective for nodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n2nd most common form of skin cancer (after BCC) arising in sun \\nexposed areas in elderly; due to malignant keratinocytes with \\nmetastatic potential.\\n\\uf0a4Etiology : Chronic UV-damage is the primary cause, \\nimmunosuppression, burns leg ulcers, chemical carcinogens \\n(e.g., tar), HPV; can occur in discoid lupus, lichen sclerosus, \\n& any scarring processes.\\n\\uf0a4History : Slow-growing, nonhealing scaly papule on sun-\\nexposed area of head, neck, dorsal hands, and forearms; \\nalso affects mucous membranes (lower lip: M >> F, smokers, \\n10% - 15% metastatic rare); rare in dark skin.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4Physical : Firm indurated papule, plaque, or nodule with \\nadherent rough scale on sun-exposed areas. Normally with \\nnecrotic crusted center. Removal of crust reveals central \\ncavity filled with necrotic keratin debris.\\n\\uf0a4Actinic keratosis is considered a precursor lesion; actinic \\ncheilitis is the precursor on lip.\\n\\uf0a4Ultimately, tumors metastasize, via the lymphatics to other \\norgans\\n\\uf0a4Investigations : Biopsy (to mid-dermis) for confirmation.\\n\\uf0a4DDx : AK, BCC, SK, amelanotic melanoma, wart.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4Management\\n\\uf0a4Wide local excision with histologic confirmation of margins.\\n\\uf0a4Lymp node biopsy indicated for suspected nodal disease\\n\\uf0a4Liquid nitrogen cryotherapy\\n\\uf0a4Mohs micrographic surgery\\n\\uf0a4Less commonly topical imiquimod or radiation\\n\\uf0a4Advide on sun protection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Etiology : Melanocyte-derived skin cancer. May arise within \\na previously existing nevus or dysplastic nevus, but ~ 70% \\narise de novo \\n\\uf0a4History : Risk factors\\n\\uf0a4Fair complexion: Red/blonde hair, blue/green eyes, tendency to \\nfreckle and burn.\\n\\uf0a4Sun exposure, particularly blistering sunburns during childhood.\\n\\uf0a4Personal of family history of melanoma; Genes involved in some \\ncases: CDKN2A, BRAF.\\n\\uf0a4Giant congenital melanocytic nevi or multiple dysplastic nevi.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Physical: Pigmented macule or plaque with some or all of the \\nfollowing features \\nABCDE of melanoma: \\n-\\nAsymmetry\\n-\\nBorders (irregular)\\n-\\nColor variegation\\n-\\nDiameter (> 6mm)\\n-\\nEvolution (lesion change by history)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\nClassically divided into subtypes based on clinical and histopathologic features:\\n1.\\nSuperficial spreading malignant melanoma – 60%-70% of melanomas.\\n2.\\nNodular melanoma.\\n3.\\nAcral-lentiginous melanoma – Most common form in blacks, Asians, and \\nHispanics, mostly on volar skin of the palms or soles and the nailbeds.\\n4.\\nLentigo maligna melanoma – Develops from a lentigo maligna, usually on the \\nface of elderly, slow-growing.\\n5.\\nAmelanotic melanoma – Pink-red.\\n6.\\nRare variants.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Superficial spreading malignant \\nmelanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Nodular melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acral-lentiginous melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lentigo maligna melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Amelanotic melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Most common sites of local and/or regional metastases-\\nDraining lymph node basins and the skin between the \\nprimary site and the lymph nodes.\\n-\\nMost common sites of systemic metastases – Lung, Liver, \\nbrain (#1 cause of death), bone, and gastrointestinal tract. \\n\\uf0a4Investigations: Dermoscopy (ABCD rule), excisional biopsy if \\nmelanomais suspected\\n\\uf0a4Most important prognostic indicator is maximal thickness of \\ntumor invasion on biopsy (Breslow depth in mm)\\n\\uf0a4DDx: BCC, blue or dysplastic nevus, SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Management\\n-\\nWide surgical excision; based on Breslow depth: 5 mm for \\nmelanoma in situ, 1 cm for melanoma <1mm, 2 cm for \\nmelanoma >1mm\\n-\\nSentinel lymph node biopsy depending on clinical\\n-\\nAdjuvant high-dose interferon & IL-2 may provide benefit for \\nmetastatic disease\\n-\\nPerfusion chemotherapy for extremity melanoma\\n-\\nRadiation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Chronic inflammatory dermatosis affecting 10%-20% of \\nchildren (esp. infants and young children)\\n\\uf0a4Etiology: Cutaneous immune dysfunction; IgE-mediated; \\ngenetics. Strong associated with personal and family \\nhistory of atopy (eczema, asthma)\\n\\uf0a4History: “Pruritus” is a hallmark (“the itch that rashes”). \\nAggravating factors: sweating, contact sensitivity, \\nsecondary infection, wool, food allergy, stress/anxiety.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Acute: Erythematous, excoriated, scaling patches and plaques; \\nmore lichenification in chronic forms.\\n\\uf0a4Distribution:\\n- Infants: Cheeks, forehead, scalp, extensor surfaces of extremities\\n- Child: Flexural surfaces- antecubital and popliteal fossae, wrists, \\nankles\\n- Adults: Hands, flexural. The prominent finding is lichenification; this \\nindicates a long – standing problem.\\n\\uf0a4Lesions can be secondarily infected with staphylococcal \\norganisms: impetigo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nInfants: Cheeks, forehead, scalp, extensor surfaces of extremities'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nChild: Flexural surfaces- antecubital and popliteal fossae, wrists, ankles'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nAdults: Hands, flexural. The prominent finding is lichenification\\n; this indicates a long – standing problem'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4DDx: Contact dermatitis, psoriasis, seborrheic dermatitis\\n\\uf0a4Investigation: Allergy or RAST testing of little value (Patch \\ntest if dermatitis pattern changes or refractory to \\ntreatment. \\n\\uf0a4Diagnosis Requires: History of an itchy skin condition (or \\nparental report of scratching/rubbing by the child)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4\\nPlus ≥3 of :\\n1. History of involvement of skin crease (antecubital, popliteal, anterior \\nankles or around the neck) or cheeks in children < 10 years\\n2. Personal history of asthma or hay fever (or history of atopic disease \\nin 1st degree relative if < 4 years of age)\\n3. History of generalized dry skin in the past year.\\n4. Visible flexural dermatitis (or eczema on the cheeks/forehead and \\nouter limbs in children < age 4 years)\\n5. Onset under the age of 2 (do not use as criterion if patient is < age 4 \\nyears)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Minor, less specific feature: \\n- xerosis, ichthyosis, palmar hyperlinearity, keratosis pilaris. \\nImmediate type 1 skin test responses, dermatitis of hands \\nand feet, cheilitis, nipple eczema, increased susceptibility to \\ncutaneous infection, perifollicular accentuation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Management\\n- Elimination of precipitating irritants: avoid wool and synthetic \\nfabrics; wear cotton clothes, humidifier at home; dietary \\nrestriction if specific verified food allergy; stress reduction.\\n-\\nSkin hydration: Baths with emollients, apply thick \\nnonfragranced emollient immediately after bath.\\n-\\nTopical steroids: 1% hydrocortisone ointment bid to face \\nand folds, midpotency steroids bid to other effected areas; \\nointments more occlusive and more effective than creams.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4Management\\n- Steroid-sparing topical immunomodulators can be used bid in \\nchildren > 2 yr: Pimecrolimus cream – mild to moderate eczema. \\nTacrolimus – moderate to severe eczema.\\n- Oral antihistamines with sedative effect may offer symptomatic \\nrelief of the associated pruritus, e.g., hydroxyzine (3-5 mg/kg/d divided \\ntid/qid)\\n- If secondarily infected: antibiotic therapy\\n- If patients refractory to conventional therapy, other systemic Tx\\nchoices include: PUVA or UVB light therapy, systemic steroids (short \\ncourses), methotrexate, cyclosporine: usually administered by \\ndermatologist')]"
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "filtered=filter_to_minimal_chunk(extracted_data)\n",
    "filtered"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "51cfd8eb",
   "metadata": {},
   "outputs": [],
   "source": [
    "#split chunk\n",
    "def split(minimal_doc):\n",
    "    text_slitter=RecursiveCharacterTextSplitter(\n",
    "        chunk_size=500,\n",
    "        chunk_overlap=20\n",
    "        \n",
    "    )\n",
    "    text_chunk= text_slitter.split_documents(minimal_doc)\n",
    "    return text_chunk\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5c77334c",
   "metadata": {},
   "outputs": [],
   "source": [
    "text_chunk=split(filtered)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c2233a58",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Common Skin Disease\\nSurangkana Veeranawin, MD\\nMSc, Queen Mary University of London\\nMmed, University of Sydney\\nDipDerm RCPS(Glas.)\\nDiplomate American Broad of Aesthetic Medicine (ABAM)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4Inflammatory disorder of pilosebaceous follicle with a 90% \\nprevalence in adolescence and young adulthood.\\n\\uf0a4History: often asymptomatic lesions (especially comedone), \\nalthough can be tender (nodules)\\n\\uf0a4Physical: two types of lesions, predominantly affect face, \\nneck, chest and back\\n- Noninflammatory; open(“black head”) and closed (“white \\nhead”) comedones\\n- Inflammatory; papules, pustule, cysts, nodule: deep lesions \\n(leave scars)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne Vulgaris\\n\\uf0a4\\n4 Major components\\n•\\nAbnormal follicular keratinization: follicular wall cells fail to \\ndesquamate to the surface in the normal manner.\\n•\\nSebum over production secondary to androgen\\n•\\nPropionibacterium acnes infection; they grow in the \\nsebum-cell mixture.\\n\\uf0a7\\nInflammation\\n\\uf0a4Other components; genetic factors, occlusive cosmetic \\nagents, medication (steroids, ACTH, androgens, lithium, \\nantiepileptics, oral contraceptives), diseases (PCOS, \\nCongenital Adrenal Hyperplasia)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nTreatment Strategies\\n- Retinoid for clearing pores and comedones for all acne \\nconditions\\n- Small inflammatory lesions \\uf0e0Topical Benzoyl Peroxide (BP) &  \\nTopical Antibiotic\\n- Large inflammatory lesions \\uf0e0Oral antibiotic'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nMild \\uf0e8\\uf0e8Topical Only\\n\\uf0a4Decrease follicular plugging\\n•\\nRetinoid \\n•\\nNightly\\n•\\nAdapalene (Differin); if can not tolerate retinoid\\n•\\nSalycilic acid wash/scrub\\n\\uf0a4Decrease P. Acne\\n•\\nTopical Antibiotic \\n•\\nClindamycin  \\n•\\nBenzoyl peroxide; bacterialcidal, decrease sebum/oil'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\nModerate or nonresponsive to topical\\n\\uf0a4Add oral antibiotic\\n•\\nTetracycline\\n250 – 500 mg twice/day\\n•\\nMinocycline \\n50 – 100 mg twice/day\\n•\\nDoxycycline\\n50 – 100 mg twice/day\\n\\uf0a4Add chemical peel  \\uf0e0Salicylic or Jessner'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acne\\n\\uf0a4Other treatment\\n- comedone extraction, intralesional cortisone injection (for \\npapulonodules, cysts), oral contraceptives (esp. anti-\\nandrogenic such as cyproterone acetate), photodynamic \\ntherapy, spironolactone (reduces androgen production; 50 \\n– 200 mg/day), dermabrasion\\n- Patients should be forewarned of acne exacerbations in \\nthe first month of systemic therapy as deep-seated acne \\ncomes to the surface. Also, systemic therapy can required 6 \\nwk before benefits are noted'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Chronic vascular & acneiform disorder\\n\\uf0a4Common chronic inflammatory disorder of pilosebaceous units \\nand vasculature of the face\\n\\uf0a4Role of Demodex mite controversial\\n\\uf0a4Increase reactivity of capillaries \\uf0e8\\uf0e8\\uf0e8Flushing\\uf0e8\\uf0e8\\uf0e8ultimately \\nleading to telangiectasia'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Easy and recurrent flushing\\n\\uf0a4Sensitive skin\\n\\uf0a4More common in fair skin\\n\\uf0a4May complain of dry and gritty eyes\\n\\uf0a4Female > male\\n\\uf0a4Peak incidence 30-50 yr'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\nEXACEBATE BY\\n\\uf0a4Heat,rapid change in temperature\\n\\uf0a4Sun exposure\\n\\uf0a4Cold\\n\\uf0a4EtOh\\n\\uf0a4Stress\\n\\uf0a4Spicy food\\n\\uf0a4Hot food/beverage\\n\\uf0a4Caffeine'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4Clinical appearance: Erythema, telangiectases, papules, \\nand pustules of central face; no comedones in contrast \\nto acne.\\n\\uf0a4Erythema of the nose is highly characteristic of rosacea\\n\\uf0a4Accompany with, sebaceous hyperplasia, seborrheic\\ndermatits & facial lymphedema more common'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Predominantly central face\\n- Forehead\\n- Cheeks\\n- Nose\\n- Chin\\n- Occasionally eyelids'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a44 Major subtypes\\n\\uf0a4Vascular rosacea ( Erythematotelangiectatic rosacea)\\n\\uf0a4Papulopustular rosacea\\n\\uf0a4Ocular rosacea: gritty, conjunctival injection, styes and \\nphotophobia. (The eye is involved in about 50% of cases)\\n\\uf0a4Nasal sebaceous hyperplasia (rhinophyma): chronic \\ninflammation may progress to rhinophyma (more common in \\nmale)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ROSACEA\\nRHINOPHYMA\\nPAPULOPUSTULAR'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf0a4Investigation\\n- Clinical diagnosis\\n- Skin biopsy to rule out lupus or sacoidosis\\n\\uf0a4Differential Diagnosis\\n- Acne              - Lupus erythematosus\\n- Sarcoidosis\\n- Seborrheic dermatitis     - Perioral dermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n\\uf07d\\nManagement\\n- Based on severity and  subtype.\\n- Lifestyle modification : Avoid triggers ; sun protection & \\navoidance.\\n- Topical antibiotic \\n\\uf096\\nMetronidazole 0.75% gel or 1% cream bid\\n\\uf096\\nSodium sulfacetamide lotion 10% bid\\n\\uf096\\nAzelaic acid QD'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n-\\nOral antibiotic (moderate to severe cases with \\ninflammatory papulopaustular component)\\n\\uf096\\nTetracycline 500 mg po BID\\n\\uf096\\nMinocycline 100 mg OD – BID\\n\\uf096\\nDoxycyline 20 mg po bid (subantimicrobial dose \\ntherapy) or 100 mg po qd-bid\\n- Isotretinoin and prednisolone for very severe cases'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Rosacea\\n- Light therapy\\n\\uf096\\nTreatment of Choice \\uf0e0IPL (400nm – 1200nm), PDL  \\n(595 nm) for telangiectases\\n\\uf096\\nAblative laser (CO2) for rhinophyma\\n- Ophthalmologist to assess for ocular involvement \\n(blepharitis, conjunctivitis)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Acute, self-limited papulosquamous inflammatory skin \\nexanthem in 15-40 yr.\\n\\uf0a4The primary lesion is an oval, salmon-colored, 1-10 cm \\nplaque that forms a round collarette of scale in the \\ncenter.\\n\\uf0a4It evolves rapidly, usually beginning with patch that \\nheralds the eruption, the so-called “herald patch.\\n\\uf0a4Clinical appearance: Scaly pink-erythematous plaques; \\npredominantly trunk affected, in “Christmas-tree” pattern'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Etiology: Possibly triggered by human herpes virus 7\\n\\uf0a4History: May be pruritic or asymptomatic; preceding URTI or \\nmild constitutional symptoms\\n\\uf0a4Lesions are found on the trunk and usually spare the face \\nand extremities\\n\\uf0a4The number of lesions is highly variable. Plaques may extend \\nto the neck and proximal limbs\\n\\uf0a4Numerous lesions may appear. A concentration of lesions on \\nthe groin and lower abdomen is highly characteristic, \\nespecially in children'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Course: Self-resolving in 6-8 weeks\\n\\uf0a4Investigations: Clinical; scraping for KOH (R/O tinea) or \\norder RPR (R/O syphilis), or skin biopsy if uncertain.\\n\\uf0a4DDx: Eczema, psoriasis, tinea corporis, syphilis, seborrheic\\ndermatitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis rosea\\n\\uf0a4Management\\n- Reassurance is key\\n- Symptomatic management of pruritus (e.g. mild topical \\nsteroids, antihistamines); mentholated lotion or sprays for \\nitching\\n- Erythromycin 250 mg, q.i.d or 25-40 mg/kg in four divided \\ndoses in children for 2 weeks may clear the eruption\\n- Light therapy (e.g. UVB) may help hasten resolution and \\nrelieve pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4Acute or chronic inflammatory disorder affecting the skin, \\nscalp hair follicles, mucous membranes, and nails (5%-\\n10%)\\n\\uf0a4Etiology: Likely an immunologically mediated reaction; \\noral erosive lichen planus associated with hepatitis C \\n(Characteristic eruption of unknown etiology)\\n\\uf0a4History: Uncommon in children. Family history is 10%. \\nPruritus common; oral lesions may or may not be \\nsymptomatic. Ask about Hep C risk factors (e.g.,'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='transfusions) for oral erosive LP. May be drug-induced.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4Physical: 7 P’s\\n- Planar (flat-topped)        - Pruritic (intense)\\n- Purple                                - Polygonal\\n- Papules                             - Penile (commonly affected)\\n- Prolonged course (up to 18 mo; longer in some case)\\n\\uf0a4Distributed on flexor surfaces, penis (glans), mouth (lacy white \\npatches or erosions – Wickham striae)\\n\\uf0a4Koebner phenomenon: appearance of lesions at sites of trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4Course: May resolve spontaneously or have chronic \\ncourse (esp. oral LP); increase risk of oral SCC in oral LP\\n\\uf0a4DDx: Drug reaction, Pityriasis rosea, Psoriasis\\n\\uf0a4Investigations: Skin biopsy if unsure of diagnosis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lichen Planus\\n\\uf0a4\\nManagement\\n\\uf0a4\\nTopical: Mild to high potency steroid bid for 2 weeks; intralesional if \\nhypertrophic/thick. Triamcinolone acetonide in adhesive base for oral lesion\\n\\uf0a4\\nSystemic: (if severe and generalized)\\n-\\nPrednisolone; a 4 weeks course starting at 1 mg/kg q.d. \\n-\\nRetinoids\\n-\\nUV therapy\\n-\\nCyclosporine\\n-\\nMetronidazole 500 mg po bid * 6 wk, sedative antihistamines for itching'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Common (1%-2% prevalence), chronic, recurrent \\ninflammatory skin disease with unpredictable course.\\n\\uf0a4Onset: any age, peaks late twenties\\n\\uf0a4Etiology: Genetic & environment factors; abnormal \\nepidermal differentiation and hyperproliferation initiated \\nand maintained primarily by T-cell\\n\\uf0a4History: Visible itchy red plaques with increase skin scaling \\nand peeling. May have joint pain (7-20%). May have \\npreceding URTI (Streptococcus infection). Worsened by'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='smoking, alcohol & stress, physical trauma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Physical: Most common chronic plaque psoriasis. \\nCharacteristic sharply defined, erythematous plaques \\nwith silvery-white scale; distributed over extensor surfaces \\n(elbows, knees), scalp, sacrum and other sites\\n-\\nNail psoriasis: Pitting, thickening, “oil-drop”, lifting of nail \\nplate off of distal nail bed (onycholysis)\\n-\\nKoebnerization = new lesions occur at sites of skin trauma \\n(as with lichen planus)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Variants: Vulgaris, palmoplantar, guttate (may follow \\nstreptococcal pharyngitis), erythrodermic, pustular, \\ninverse (affects folds and flexor surfaces)\\n\\uf0a4Drug may precipitate or exacerbate psoriasis: \\nAntimalarials, clonidine, indomethacin, iodine, lithium, \\nNSAIDS, quinidine, some beta-blockers, steoids\\nwithdrawal and terfenadine.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Plaques type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Erythroderma)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Guttate type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Palmoplantar)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis (Inverse type)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4In 10-20% may be associated with psoriatic arthritis, most \\ncommonly of the small joints of the hands and feet; \\nrequires systemic Tx\\n\\uf0a4Investigation: Clinical diagnosis; skin biopsy if uncertain\\n\\uf0a4DDx: Drug reaction, eczema. Lichen planus, pityriasis\\nrubra pilaris'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Topical\\n- Steroids; Fast, temporary relief (atrophy, telangiectasia)\\n-\\nCalcipotriol ointment, 100g bid. on weekdays as \\ntolerated + topical steroid bid., weekends\\n-\\nTazarotene 0.05%, 0.1% cream qhs\\n-\\nTar preparations; low cost, effective (limited by odor, \\nirritation, clothing stains)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Systemic\\n-\\nMethotrexate; Folic acid antagonist that inhibits DNA \\nsynthesis & causes immunosuppression (Bone marrow and \\nhepatic toxicity, nausea, anorexia, fatique, oral ulceration)\\n-\\nCyclosporine; Immunosuppressant that inhibits IL-2 \\nproduction & thus reduces T-cell proliferation (Renal toxicity, \\nhypertension)\\n-\\nAcitretin; Inhibits cell replication by modulating cellular \\ndifferentiation within the epidermis. May combine with PUVA \\nor UVB.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Phototherapy\\n-\\nUVB (narrowband ultraviolet B); administer 2-5 times per \\nweek.\\nor\\n- PUVA; Interferes (Psoralen plus ultravioletA) with DNA \\nsynthesis, decreases cellular proliferation, and induces \\napoptosis of cutaneous lymphocytes leading to localized \\nimmunosuppression. Administer 3 times per week until clear, \\nthen tapered. (Skin cancer development, photoaging)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Newer Biological Agents\\n-\\nAlefacept ; Fusion protein of Fc receptor of human lgG1 and LFA3. (IM; \\nwhen effective long remissions; monitoring of CD4 q wk; slow onset)\\n-\\nEfalizumab ; Humanized monoclonal antibody to CD11 a; blocks LFA-1/ \\nICAM interaction. (SC; rapidly effective, but rebound; risk of \\nthrombocytopenia)\\n-\\nEtanercept ; Fusion protein directed against soluble TNFa(SC; effective for \\npsoriasis & psoriatic arthritis; rapid onset; no monitoring; use +/- MTX)\\n-'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='-\\nInfliximab ; Chimeric monoclonal antibody against TNFa (IV; Fast onset and \\nvery effective; must do PPD; infusion reactions.\\n-\\nAdalimumab ; Fully humanized anti-TNF monoclonal antibody (SC; newest \\nof the biologics, still being studied.\\nNote TNF drugs avoid or use with caution in presence of CHF, demyelination \\ndisorders. Increased risk of opportunistic infections.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Psoriasis\\n\\uf0a4Scalp; 10% salicylic acid in mineral oil qhs, tar shampoo \\nqd, steroid lotion, calcipotriol lotion.\\n\\uf0a4Nails; Intradermal triamcinolone acetonide injections \\n(painful), methotrexate, new biologics.\\n\\uf0a4Generalized psoriasis (>10% BSA) benefits from systemic \\ntherapy, best administered by an experienced physician'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4Acquired skin disorder characterized by well-defined \\nareas of complete epidermal depigmentation; various \\npathogenesis theories; likely a large autoimmune \\ncomponent\\n\\uf0a4History; Asymptomatic: 50% present before age 20, 1-2% \\naffected, rare in infancy & old age\\n\\uf0a4Associated with immune disorder; therefore workup for \\nthyroid disease, diabetes, pernicious anemia and other \\nautoimmune diseases occasionally indicated'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4Physical: Stark white patch with well-demarcated border; \\nhair in vitiligo patches appears white or gray\\n\\uf0a4Increased risk of sunburn and skin cancer in amelanotic\\nareas\\n\\uf0a4Investigations; Wood’s lamp accentuates areas of vitiligo\\n& helps determine extent; consider TSH and fasting blood \\nglucose\\n\\uf0a4DDx; Leprosy, pityriasis alba, tinea vesicolor, tuberous \\nsclerosis, nevus depigmentosus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Vitiligo\\n\\uf0a4\\nManagement\\n-\\nMainly for cosmetic, psychological burden\\n-\\nTopical steroids and new topical immunomodulators (tacrolimus & pimecrolimus), \\nPUVA, NB-UVB, phototherapy\\n-\\nCamouflage makeup\\n-\\nNote that facial and more proximal lesions respond better than acral lesions\\n-\\nSurgical transplants can be considered in stable vitiligo\\n-\\nIf extensive, can consider bleaching of nonaffected areas to result in total white \\ncolor\\n-\\n-Advise; importance of sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4Etiology: Self-limited viral infection of skin caused by \\npoxvirus affecting mainly children.\\n\\uf0a4Immunocompromised patients (e.g., HIV) may develop \\nmore widespread and larger lesions\\n\\uf0a4History: Asymptomatic; occasional perilesional pruritus, \\nvery common in children. Spread by direct contact or \\nautoinoculation. Lesions tend to be more numerous and \\nspread rapidly in patients with atopic dermatits.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4Physical: 2- to 6- mm firm, flesh colored, dome-shaped, \\numbilicated pearly papules; most common affected sites –\\ntrunk and face of children, genital/inner thigh of sexually \\nactive adults\\n\\uf0a4Molluscum papules in a child in the periorbital region. \\nLesions can be spread by picking and scratching. Lesions \\nwill be resolve with development of cellular immunity. \\n\\uf0a4Course: lesions typically involute spontaneously within 9-12 \\nmo; may develop adjacent eczema (10%)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4Investigation: clinical diagnosis, biopsy if uncertain\\n\\uf0a4DDx: BCC, milia, other infection, warts'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum\\n\\uf0a4\\nManagement\\n-\\nObservation\\n-\\nLiquid Nitrogen Cryotherapy\\n-\\nCurettage: may be uncomfortable\\n-\\nPapule incision with a scalpel blades or at home sharp fingernail and expression of \\ncontents\\n-\\nTopical cantharidin 0.7%: Blistering will occur\\n-\\nImiquimod cream, Tretinoin cream\\n-\\nIn children with widespread involvement, may consider oral cimetidine (40 \\nmg/kg/d ) for 2 mo.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Molluscum Contagiosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4Etiology : Common superficial cutaneous fungal infection \\ncaused by Malassezia furfur (Pityrosporum orbiculare), The \\norganism is part of normal skin\\n\\uf0a4History : May itch but usually asymptomatic, young adults \\ntypically affected (years of higher sebaceous activity) ; \\ncommonly recurs (40-60%) ; more common in hot and humid \\nenvironments.\\n\\uf0a4Cushing disease, pregnancy, mulnutrition, corticosteroid \\ntherapy, immunosuppression, oral contraceptives may lower'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='resistance, allowing this normally non-pathogenic resident \\nyeast to poliferate'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tinea Versicolor)\\n\\uf0a4Physical : Round to oval macules and patches on the \\ntrunk extending to the upper arms, neck, abdomen; \\ndifferent colors: White, orange-brown, dark-brown; very \\nfine scale; postinflammatory hypopigmentation is often \\nnoted rather than initial erythema.\\n\\uf0a4Investigations: KOH test reveals diagnostic “spaghetti & \\nmeatballs” (hyphae & spores); Wood’s lamp shows \\nyellow-brown fluorescence. Skin biopsy if diagnosis \\nuncertain.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='uncertain.\\n\\uf0a4DDx : Tinea corporis, vitiligo, psoriasis.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Pityriasis Versicolor (Tianea Versicolor)\\n\\uf0a4Management\\n\\uf0a4Topical or systemic treatment.\\n\\uf0a4Nizoral shampoo (ketoconazole 2%) applied onto dampened \\ntrunk skin, lathered for 5 min before rinsing, x 3 d.\\n\\uf0a4Topical selenium sulfide 2.5% shampoo applied for 15 min x 3 d.\\n\\uf0a4Topical nizoral cream 2% (ketoconazole) bid x 2 wk.\\n\\uf0a4Systemic ketoconazole 200 mg po qd x 5 – 7 d or fluconazole \\n400 mg x 1. Postinflammatory hypopigmentation may persist for \\n6 – 12 mo.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='6 – 12 mo.\\n\\uf0a4Even with treatment, tendency to recur in summer.\\n\\uf0a4Zinc pyrithione soap lather may be applied to the body 1 – 3 \\ntimes weekly for prevention.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4Dermatophyte digest and invade keratin then infect skin, \\nnails and hair; incubation period = 1-3 weeks\\n\\uf0a4Trychophyton, Microsporum, Epidermophyton species \\ncommonly involved.\\n\\uf0a4Risk Factors; Hot, humid environment, sweating or \\nmaceration of the skin, occlusive footwear, Diabetes \\nmellitus, immunosuppression\\n\\uf0a4History: Asymptomatic; occasionally mild pruritus'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4Physical; Scalp hair and general body surfaces mostly \\naffected during childhood; hand, foot or nail infections \\nare more common after puberty\\n\\uf0a4Immunologic response to a dermatophyte infection may \\nresult in a dermatophytid reaction: Vesicular eruption on \\nacral surfaces, especially the palms'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea (Dermatophyte) Infection\\n\\uf0a4Investigations; Skin scraping analysis with KOH prep –\\nSeptate hyphae branching at various angles are seen; \\nfungal culture\\n\\uf0a4DDx; Eczema, granuloma annulare, psoriasis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4Caused by invasion of stratum corneum and hair shaft with fungal \\nhyphae.\\n\\uf0a4Four clinical infection patterns;\\n-\\nSeborrheic dermatitis type- Diffuse, patchy scale on scalp\\n-\\nBlack dot pattern- hyphae invade hair shaft. Hair then broke at \\nscalp surface. Broken shaft like black dots. Round area of alopecia \\nwithout inflammation\\n-\\nInflammation tinea capitis (kerion)- Deep boggy round masses with \\npustules, surface exudate\\n-'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='-\\nPustular- Pustules areas without scaling, significant hair loss may be \\npresent, look like scalp bacterial infection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic dermatitis type – Tinea\\nCapitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Black dot pattern – Tinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Inflammation tinea capitis (kerion) –\\nTinea Capitis'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Tinea Capitis\\n\\uf0a4Management\\n-\\nExamine sibling and household members, clean or discard \\ncontaminated objects.\\n-\\nGriseofulvin; usually 6-12 weeks\\n-\\nItraconazole and fluconazole; taken for 4-8 weeks. A single dose of \\n150 mg once weekly for 4 weeks also be effective for older children\\n-\\nShampoo with selenium sulfide 1% or ketoconazole every other day \\nfor the first 2 weeks, then twice weekly throughout course of rest of \\noral therapy. Shampoo is left for 5 min\\n-'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='-\\nConsider suppression kerion inflammation with prednisolone 1-2 \\nmg/kg qd or intralesional triamcinolone 10 mg/cc'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4Common form of septal panniculitis that is usually a reactive skin response to \\nan associated trigger\\n-\\nInfections; Bacterial (e.g., streptococcal pharyngitis), microbacterial\\n(tuberculosis)\\n-\\nDrugs; e.g., oral contraceptives, sulfonamides\\n-\\nSarcoidosis\\n-\\nInflammatory bowel disease\\n-\\nBehcet disease\\n-\\nMalignancy\\n-\\n- Pregnency'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4History; Lesions may be associated with fever, malaise, \\nleg edema and arthralgia. Resolution after 2-6 wk\\n\\uf0a4Physical; painful, dull, erythematous nodules 1-5 cm in \\ndiameter, located on anterior lower legs of young \\nwoman. No ulceration, discharge or scarring\\n\\uf0a4Investigation; Through review of systems: CBC, UA, chest \\nx-ray and throat swab\\n\\uf0a4DDx; Insect bite reaction, erysipelas, urticaria'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Erythema Nodosum\\n\\uf0a4Management\\n-\\nInvestigate for and treat underlying cause.\\n-\\nMost patients benefit from bed rest, applying ice or cool \\ncompresses, elevating legs & NSAIDs\\n-\\nLess common Tx choice; Oral prednisolone, colchicine, \\ndapsone'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4An inflammatory condition of degenerative collagen. \\nWhen present, it is often associated with diabetes\\n\\uf0a4Lesions usually develop slowly and are often \\nasymptomatic, onset may occur at any age but the \\ndisease most common starts at 3rd – 4th decade. About \\n75% of those affected are women'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4Physical Findings\\n\\uf0a4Lesion are usually limited to the anterior shins but may be seen \\non calve and thighs, and rarely on the arms, hands, feet and \\nscalp.\\n\\uf0a4They begin as round, violaceous patches and slowly expand. \\nThe advancing border is red, and the central area turns a \\ncharacteristic orange-yellow brown. The central area atrophies \\nand shows a shiny, waxy surface with prominent telangiectasias.\\n\\uf0a4Ulceration may occur, particulary after trauma, in about 15% of'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='cases. These ulcers are exquisitely tender.\\n\\uf0a4The number or severity of lesions or ulcerations has not been \\ncorrelated with the degree of diabetic control.\\n\\uf0a4The course is unpredictable. Lesions usually heal with atrophic \\nscarring, or can be chronic and recurrent.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Necrobiosis lipodica\\n\\uf0a4Treatment\\n\\uf0a4Topical and intralesional steroids slow the inflammation but may \\npromote further atrophy. Middle- to high-potency \\ncorticosteroids can be used under occlusion.\\n\\uf0a4Intralesional injections of triamcinolone acetonide 10 mg/mL \\ncanbe helpful.\\n\\uf0a4A short course (5-6 weeks) of oral corticosteroids can be \\nconsidered if disease activity and symptoms are severse, but this \\nis rarely the case.\\n\\uf0a4Pentoxifylline (Trental) 400mg t.i.d. has been advocated by'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='some and has been used in combination with low-dose aspirin \\nfor ulcerating necrobiosis lipoidica. \\n\\uf0a4Skin grafting can be performed for extensive disease.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d\\nCommon idiopathic benign epidermal growth\\n\\uf07d\\nCommon in fourth decade\\n\\uf07d\\nMales and females equally affected\\n\\uf07d\\nMore common in fair skin\\n\\uf07d\\nPossibly autosomal dominant\\n\\uf07d\\nGradual development; occasionally pruritic or sore'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d\\nWell circumscribed  epidermal growth, raised lesions\\n\\uf07d\\nWaxy round-oval papules and plaques with verrucous or \\ncrusted surface. Sharp border\\n\\uf07d\\n“Stuck on” appearance \\n\\uf07d\\nStarts as light brown macule \\nlarger and verrucous with \\ntime\\n\\uf07d\\nAlso, smooth-surfaced lesions contain dark or light round \\nhorn pearls embedded in the lesion or protruding from the \\nsurface. \\n\\uf07d\\nVariably pigmented and size\\n\\uf07d\\nMost commonly: trunk, neck, arms, scalp; wide range of size'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4Leser-Trelat sign: Sudden, eruptive seborrheic keratoses in \\nelderly individuals, often with inflammatory base may be \\na sign of an associated internal (stomach cancer & \\nothers) malignancy as part of paraneoplastic syndrome'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf0a4Investigation: Clinical diagnosis; skin biopsy if uncertain.\\n\\uf0a4DDx: AK, BCC, lentigo, melanoma, nevus, skin tag, wart'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Seborrheic Keratosis - SK\\n\\uf07d\\nTreatment may be indicated for symptomatic lesions which \\nare inflamed, irritated or bleeding.\\n\\uf07d\\nTHERAPIES\\n◦\\nCryotherapy; for flat to minimally raised lesions. \\n◦\\nLight cautery/electrodessication \\n◦\\nShave excision\\n◦\\nLaser\\n\\uf096\\nNot effective for thicker lesions \\n\\uf096\\nRuby (694nm)\\n\\uf096\\nAlexandrite (755nm)\\n\\uf096\\nCO2\\n\\uf096\\nErbium'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d\\nMost common precancerous lesions in humans, and more \\nprevalent in fair-skinned individuals who tan poorly and burn \\neasily.\\n\\uf07d\\nFound in sun-exposed skin \\n◦\\nFace, ears\\n◦\\nNeck, forearms\\n◦\\nDorsal hands\\n\\uf07d\\nOutdoor occupations, ionizing radiation, \\nand arsenic exposure'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d\\nCommon in skin type I-III\\n\\uf07d\\nSecondary to cumulative keratinocyte damage\\n\\uf07d\\nAtypical keratinocytes confined to epidermal basal layer\\n\\uf07d\\n< 1% progress to skin cancer (squamous cell carcinoma, SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf0a4Clinical appearance\\n- Slightly erythematous, rough, scaly papules on sun-exposed \\nareas\\n- May be difficult to see, but often feel rough: Palpation is \\nessential to diagnosis.\\n- Most commonly in the elderly\\n- DDx: BCC, Bowen disease, SCC\\n- Investigation: Biopsy if recurrent, unresponsive to treatment, \\nor pronounced hyperkeratosis and induration'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n\\uf07d\\nTreatment options\\n◦\\nTopical\\n\\uf096\\n5%  5-flourouracil  (Carac, Efudex) applied bid for 2-4 \\nwk\\n\\uf096\\n5% Imiquimod (Aldara) applied three to five times \\nweekly for 12 wk\\n\\uf096\\nExpect \\nerythema, irritated, inflamed and crusting; \\nfollow-up visit in 1-2 wk to evaluate severity of side \\neffects'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Actinic Keratosis - AK\\n◦\\nLiquid Nitrogen Cryotherapy for limited lesions\\n◦\\nElectrodesication and curettage, CO2 laser\\n◦\\nDermabrasion\\n◦\\nChemical peel (for numerous AKs)  \\n\\uf096\\nSerial medium depth \\nTCA\\n◦\\nLight Therapy\\n\\uf096\\nPDT with ALA. Pulsed CO2\\nSun-awareness and protection advice'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Most common cutaneous malignancy derived from stem \\ncells of epidermis. Locally invasive, slow-growing, rarely \\nmetastasizes (unless patients is immunocompromised)\\n\\uf0a4Etiology: Chronic UV exposure (Cumulative sun exposure \\nis primary risk factor), radiation, immunosuppression, \\ngenetics (e.g., nevoid basal cell carcinoma syndrome)\\n\\uf0a4History: Persistent, nonhealing papule or nodule that \\nulcerates or bleeds (beefy-red smooth erosive nodule).'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Common in elderly (most common after 40) Caucasians.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Physical: Pearly papule or nodule with telangiectases, \\nrolled border; central crust or ulceration.\\n\\uf0a4Distributed mostly on sun-exposed areas, i.e., head and \\nneck (85%). Variants: Superficial, nodular, sclerosing\\n(morpheaform), pigmented\\n\\uf0a4DDx: Melanoma, nevus, SCC\\n\\uf0a4Investigations: Biopsy must be performed to confirm \\ndiagnosis and classify subtype.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Physical Findings\\n- Nodular BCC: Most common variant. A pearly white, \\nalmost translucent, dome-shaped papule with overlying \\ntelangiectasias. Papule or nodule enlarges slowly, may \\nbecome flattened in center or may develop a raised, rolled, \\ntranslucent border. Frequently ulcerates, bleeds, becomes \\ncrusted in center'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n-\\nPigmented BCC: contains melanin, may therefore \\nresemble melanoma\\n-\\nSuperficial BCC: least aggressive form. More commonly \\non trunk, extremities. Circumscribed, round to oval, red, \\nscaling plaque resembles eczema, psoriasis, \\nextramammary Paget disease or Bowen disease\\n-\\nSclerosing BCC : Most subtle and least common variant. \\nSmooth, pale white to yellow papules. Resembles scar \\ntissue. Borders may be difficult to discern. Higher rate of \\nrecurrence'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nNodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nPigmented BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSuperficial BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\nSclerosing BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Management\\n- Advise that metastases and death are extremely rare. Vast \\nmajority cause no major problem, but should be treated\\n- Without treatment, BCCs persist, enlarge, ulcerate, invade, \\ndestroy surrounding structures \\n-\\nTx options depend on histological subtype and location: \\nLiquid nitrogen cryotherapy (requires experience), \\ncurettage & electrodessication (most common Tx), excision, \\nMohs micrographic surgery, imiquimod cream for superficial'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='subtype, 5-FU, CO2 laser, radiation therapy\\n-\\nAdvise on sun protection'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Electrosurgery of obvious tumor. The 5 year cure rate \\napproach 92%\\n\\uf0a4Primary excision is preferred for non-facial, well-defined \\nnodular. The 5 year rate approach 90%\\n\\uf0a4Mohs microsurgery is a highly specialized, tissue-sparing \\nmethod of excision used for difficult tumors with \\ncontiguous growth. It is also used for recurrent BCC, \\nhistological  aggressive forms of BCC, such as sclerotic \\nBCCs, and tumors in anatomically important locations'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='such as around eyes, nasal alar, mouth and ears.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Basal Cell Carcinoma - BCC\\n\\uf0a4Radiation therapy may be useful for difficult-to-treat \\ntumors, such as eyelids, and for patients unable to \\ntolerate surgery. The 5 year cure rates are roughly 90%\\n\\uf0a4Photodynamic therapy is an evolving chemotherapeutic \\nmodality for superficial BCC\\n\\uf0a4Topical imiquimod 5% cream is an immune response \\nmodifier shown to be about 85% effective or better for \\nsuperficial BCC. It is less effective for nodular BCC'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n2nd most common form of skin cancer (after BCC) arising in sun \\nexposed areas in elderly; due to malignant keratinocytes with \\nmetastatic potential.\\n\\uf0a4Etiology : Chronic UV-damage is the primary cause, \\nimmunosuppression, burns leg ulcers, chemical carcinogens \\n(e.g., tar), HPV; can occur in discoid lupus, lichen sclerosus, \\n& any scarring processes.\\n\\uf0a4History : Slow-growing, nonhealing scaly papule on sun-\\nexposed area of head, neck, dorsal hands, and forearms;'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='also affects mucous membranes (lower lip: M >> F, smokers, \\n10% - 15% metastatic rare); rare in dark skin.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4Physical : Firm indurated papule, plaque, or nodule with \\nadherent rough scale on sun-exposed areas. Normally with \\nnecrotic crusted center. Removal of crust reveals central \\ncavity filled with necrotic keratin debris.\\n\\uf0a4Actinic keratosis is considered a precursor lesion; actinic \\ncheilitis is the precursor on lip.\\n\\uf0a4Ultimately, tumors metastasize, via the lymphatics to other \\norgans\\n\\uf0a4Investigations : Biopsy (to mid-dermis) for confirmation.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4DDx : AK, BCC, SK, amelanotic melanoma, wart.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Squamous Cell Carcinoma (SCC)\\n\\uf0a4Management\\n\\uf0a4Wide local excision with histologic confirmation of margins.\\n\\uf0a4Lymp node biopsy indicated for suspected nodal disease\\n\\uf0a4Liquid nitrogen cryotherapy\\n\\uf0a4Mohs micrographic surgery\\n\\uf0a4Less commonly topical imiquimod or radiation\\n\\uf0a4Advide on sun protection.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Etiology : Melanocyte-derived skin cancer. May arise within \\na previously existing nevus or dysplastic nevus, but ~ 70% \\narise de novo \\n\\uf0a4History : Risk factors\\n\\uf0a4Fair complexion: Red/blonde hair, blue/green eyes, tendency to \\nfreckle and burn.\\n\\uf0a4Sun exposure, particularly blistering sunburns during childhood.\\n\\uf0a4Personal of family history of melanoma; Genes involved in some \\ncases: CDKN2A, BRAF.\\n\\uf0a4Giant congenital melanocytic nevi or multiple dysplastic nevi.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Physical: Pigmented macule or plaque with some or all of the \\nfollowing features \\nABCDE of melanoma: \\n-\\nAsymmetry\\n-\\nBorders (irregular)\\n-\\nColor variegation\\n-\\nDiameter (> 6mm)\\n-\\nEvolution (lesion change by history)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\nClassically divided into subtypes based on clinical and histopathologic features:\\n1.\\nSuperficial spreading malignant melanoma – 60%-70% of melanomas.\\n2.\\nNodular melanoma.\\n3.\\nAcral-lentiginous melanoma – Most common form in blacks, Asians, and \\nHispanics, mostly on volar skin of the palms or soles and the nailbeds.\\n4.\\nLentigo maligna melanoma – Develops from a lentigo maligna, usually on the \\nface of elderly, slow-growing.\\n5.\\nAmelanotic melanoma – Pink-red.\\n6.\\nRare variants.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Superficial spreading malignant \\nmelanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Nodular melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Acral-lentiginous melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Lentigo maligna melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Amelanotic melanoma'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Most common sites of local and/or regional metastases-\\nDraining lymph node basins and the skin between the \\nprimary site and the lymph nodes.\\n-\\nMost common sites of systemic metastases – Lung, Liver, \\nbrain (#1 cause of death), bone, and gastrointestinal tract. \\n\\uf0a4Investigations: Dermoscopy (ABCD rule), excisional biopsy if \\nmelanomais suspected\\n\\uf0a4Most important prognostic indicator is maximal thickness of \\ntumor invasion on biopsy (Breslow depth in mm)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4DDx: BCC, blue or dysplastic nevus, SK'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Melanoma\\n\\uf0a4Management\\n-\\nWide surgical excision; based on Breslow depth: 5 mm for \\nmelanoma in situ, 1 cm for melanoma <1mm, 2 cm for \\nmelanoma >1mm\\n-\\nSentinel lymph node biopsy depending on clinical\\n-\\nAdjuvant high-dose interferon & IL-2 may provide benefit for \\nmetastatic disease\\n-\\nPerfusion chemotherapy for extremity melanoma\\n-\\nRadiation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Chronic inflammatory dermatosis affecting 10%-20% of \\nchildren (esp. infants and young children)\\n\\uf0a4Etiology: Cutaneous immune dysfunction; IgE-mediated; \\ngenetics. Strong associated with personal and family \\nhistory of atopy (eczema, asthma)\\n\\uf0a4History: “Pruritus” is a hallmark (“the itch that rashes”). \\nAggravating factors: sweating, contact sensitivity, \\nsecondary infection, wool, food allergy, stress/anxiety.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Acute: Erythematous, excoriated, scaling patches and plaques; \\nmore lichenification in chronic forms.\\n\\uf0a4Distribution:\\n- Infants: Cheeks, forehead, scalp, extensor surfaces of extremities\\n- Child: Flexural surfaces- antecubital and popliteal fossae, wrists, \\nankles\\n- Adults: Hands, flexural. The prominent finding is lichenification; this \\nindicates a long – standing problem.\\n\\uf0a4Lesions can be secondarily infected with staphylococcal \\norganisms: impetigo'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nInfants: Cheeks, forehead, scalp, extensor surfaces of extremities'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nChild: Flexural surfaces- antecubital and popliteal fossae, wrists, ankles'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\nAdults: Hands, flexural. The prominent finding is lichenification\\n; this indicates a long – standing problem'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4DDx: Contact dermatitis, psoriasis, seborrheic dermatitis\\n\\uf0a4Investigation: Allergy or RAST testing of little value (Patch \\ntest if dermatitis pattern changes or refractory to \\ntreatment. \\n\\uf0a4Diagnosis Requires: History of an itchy skin condition (or \\nparental report of scratching/rubbing by the child)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4\\nPlus ≥3 of :\\n1. History of involvement of skin crease (antecubital, popliteal, anterior \\nankles or around the neck) or cheeks in children < 10 years\\n2. Personal history of asthma or hay fever (or history of atopic disease \\nin 1st degree relative if < 4 years of age)\\n3. History of generalized dry skin in the past year.\\n4. Visible flexural dermatitis (or eczema on the cheeks/forehead and \\nouter limbs in children < age 4 years)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='5. Onset under the age of 2 (do not use as criterion if patient is < age 4 \\nyears)'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Minor, less specific feature: \\n- xerosis, ichthyosis, palmar hyperlinearity, keratosis pilaris. \\nImmediate type 1 skin test responses, dermatitis of hands \\nand feet, cheilitis, nipple eczema, increased susceptibility to \\ncutaneous infection, perifollicular accentuation'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='Atopic Dermatitis\\n\\uf0a4Management\\n- Elimination of precipitating irritants: avoid wool and synthetic \\nfabrics; wear cotton clothes, humidifier at home; dietary \\nrestriction if specific verified food allergy; stress reduction.\\n-\\nSkin hydration: Baths with emollients, apply thick \\nnonfragranced emollient immediately after bath.\\n-\\nTopical steroids: 1% hydrocortisone ointment bid to face \\nand folds, midpotency steroids bid to other effected areas;'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='ointments more occlusive and more effective than creams.'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='\\uf0a4Management\\n- Steroid-sparing topical immunomodulators can be used bid in \\nchildren > 2 yr: Pimecrolimus cream – mild to moderate eczema. \\nTacrolimus – moderate to severe eczema.\\n- Oral antihistamines with sedative effect may offer symptomatic \\nrelief of the associated pruritus, e.g., hydroxyzine (3-5 mg/kg/d divided \\ntid/qid)\\n- If secondarily infected: antibiotic therapy\\n- If patients refractory to conventional therapy, other systemic Tx'),\n",
       " Document(metadata={'source': 'data/3-Lecture-Common-Skin-Disease-2019.pdf'}, page_content='choices include: PUVA or UVB light therapy, systemic steroids (short \\ncourses), methotrexate, cyclosporine: usually administered by \\ndermatologist')]"
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_chunk"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "54f17d3c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "139"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(text_chunk)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "14c5c00f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.embeddings import HuggingFaceBgeEmbeddings\n",
    "\n",
    "def download_embeddings():\n",
    "    model_name=\"sentence-transformers/all-MiniLM-L6-v2\"\n",
    "    embeddings=HuggingFaceBgeEmbeddings(model_name=model_name)\n",
    "    return embeddings    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "68350b41",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Manodya\\AppData\\Local\\Temp\\ipykernel_2532\\1364964222.py:5: LangChainDeprecationWarning: The class `HuggingFaceBgeEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings=HuggingFaceBgeEmbeddings(model_name=model_name)\n"
     ]
    }
   ],
   "source": [
    "embedding=download_embeddings()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6afcb6e4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "HuggingFaceBgeEmbeddings(client=SentenceTransformer(\n",
       "  (0): Transformer({'max_seq_length': 256, 'do_lower_case': False}) with Transformer model: BertModel \n",
       "  (1): Pooling({'word_embedding_dimension': 384, 'pooling_mode_cls_token': False, 'pooling_mode_mean_tokens': True, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True})\n",
       "  (2): Normalize()\n",
       "), model_name='sentence-transformers/all-MiniLM-L6-v2', cache_folder=None, model_kwargs={}, encode_kwargs={}, query_instruction='Represent this question for searching relevant passages: ', embed_instruction='', show_progress=False)"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "21afd48d",
   "metadata": {},
   "outputs": [],
   "source": [
    "vector=embedding.embed_query(\"Hello world\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ecdf0904",
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'vector' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mNameError\u001b[39m                                 Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[18]\u001b[39m\u001b[32m, line 1\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m1\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33mvector length:\u001b[39m\u001b[33m\"\u001b[39m,\u001b[38;5;28mlen\u001b[39m(\u001b[43mvector\u001b[49m))\n",
      "\u001b[31mNameError\u001b[39m: name 'vector' is not defined"
     ]
    }
   ],
   "source": [
    "print(\"vector length:\",len(vector))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "52a049cf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os \n",
    "load_dotenv()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6bbcea1d",
   "metadata": {},
   "outputs": [],
   "source": [
    "OPENAI_API_KEY=os.getenv(\"OPENAI_API_KEY\")\n",
    "PINECONE_API_KEY=os.getenv(\"PINECONE_API_KEY\")\n",
    "\n",
    "os.environ[\"OPENAI_API_KEY\"]=OPENAI_API_KEY\n",
    "os.environ[\"PINECONE_API_KEY\"]=PINECONE_API_KEY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "98a15114",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import Pinecone\n",
    "pinecone_api_key=PINECONE_API_KEY\n",
    "\n",
    "pc=Pinecone(api_key=pinecone_api_key)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "454b550a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<pinecone.pinecone.Pinecone at 0x2b1f2ee7140>"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6c2539c5",
   "metadata": {},
   "outputs": [
    {
     "ename": "PineconeApiException",
     "evalue": "(400)\nReason: Bad Request\nHTTP response headers: HTTPHeaderDict({'content-type': 'text/plain; charset=utf-8', 'access-control-allow-origin': '*', 'vary': 'origin,access-control-request-method,access-control-request-headers', 'access-control-expose-headers': '*', 'x-pinecone-api-version': '2025-04', 'x-cloud-trace-context': '34e4dab27605130dd896766e1bc5504b', 'date': 'Thu, 13 Nov 2025 02:17:41 GMT', 'server': 'Google Frontend', 'Content-Length': '125', 'Via': '1.1 google', 'Alt-Svc': 'h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000'})\nHTTP response body: {\"error\":{\"code\":\"INVALID_ARGUMENT\",\"message\":\"Name must consist of lower case alphanumeric characters or '-'\"},\"status\":400}\n",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mPineconeApiException\u001b[39m                      Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[16]\u001b[39m\u001b[32m, line 5\u001b[39m\n\u001b[32m      3\u001b[39m index=\u001b[33m\"\u001b[39m\u001b[33mmedi_bot\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m      4\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m pc.has_index(index):\n\u001b[32m----> \u001b[39m\u001b[32m5\u001b[39m     \u001b[43mpc\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcreate_index\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m      6\u001b[39m \u001b[43m        \u001b[49m\u001b[43mname\u001b[49m\u001b[43m=\u001b[49m\u001b[43mindex\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m      7\u001b[39m \u001b[43m        \u001b[49m\u001b[43mdimension\u001b[49m\u001b[43m=\u001b[49m\u001b[32;43m384\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m      8\u001b[39m \u001b[43m        \u001b[49m\u001b[43mmetric\u001b[49m\u001b[43m=\u001b[49m\u001b[43m \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mcosine\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m \u001b[49m\u001b[43m,\u001b[49m\u001b[38;5;66;43;03m#cosine  similarity,\u001b[39;49;00m\n\u001b[32m      9\u001b[39m \u001b[43m        \u001b[49m\u001b[43mspec\u001b[49m\u001b[43m=\u001b[49m\u001b[43mServerlessSpec\u001b[49m\u001b[43m(\u001b[49m\u001b[43mcloud\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43maws\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43mregion\u001b[49m\u001b[43m=\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mus-east-1\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;66;43;03m#specification\u001b[39;49;00m\n\u001b[32m     10\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     11\u001b[39m index=pc.index(index)\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\pinecone.py:334\u001b[39m, in \u001b[36mPinecone.create_index\u001b[39m\u001b[34m(self, name, spec, dimension, metric, timeout, deletion_protection, vector_type, tags)\u001b[39m\n\u001b[32m    323\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mcreate_index\u001b[39m(\n\u001b[32m    324\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m    325\u001b[39m     name: \u001b[38;5;28mstr\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m    332\u001b[39m     tags: Optional[Dict[\u001b[38;5;28mstr\u001b[39m, \u001b[38;5;28mstr\u001b[39m]] = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m    333\u001b[39m ) -> \u001b[33m\"\u001b[39m\u001b[33mIndexModel\u001b[39m\u001b[33m\"\u001b[39m:\n\u001b[32m--> \u001b[39m\u001b[32m334\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mdb\u001b[49m\u001b[43m.\u001b[49m\u001b[43mindex\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcreate\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    335\u001b[39m \u001b[43m        \u001b[49m\u001b[43mname\u001b[49m\u001b[43m=\u001b[49m\u001b[43mname\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    336\u001b[39m \u001b[43m        \u001b[49m\u001b[43mspec\u001b[49m\u001b[43m=\u001b[49m\u001b[43mspec\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    337\u001b[39m \u001b[43m        \u001b[49m\u001b[43mdimension\u001b[49m\u001b[43m=\u001b[49m\u001b[43mdimension\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    338\u001b[39m \u001b[43m        \u001b[49m\u001b[43mmetric\u001b[49m\u001b[43m=\u001b[49m\u001b[43mmetric\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    339\u001b[39m \u001b[43m        \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtimeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    340\u001b[39m \u001b[43m        \u001b[49m\u001b[43mdeletion_protection\u001b[49m\u001b[43m=\u001b[49m\u001b[43mdeletion_protection\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    341\u001b[39m \u001b[43m        \u001b[49m\u001b[43mvector_type\u001b[49m\u001b[43m=\u001b[49m\u001b[43mvector_type\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    342\u001b[39m \u001b[43m        \u001b[49m\u001b[43mtags\u001b[49m\u001b[43m=\u001b[49m\u001b[43mtags\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    343\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\utils\\require_kwargs.py:14\u001b[39m, in \u001b[36mrequire_kwargs.<locals>.wrapper\u001b[39m\u001b[34m(*args, **kwargs)\u001b[39m\n\u001b[32m      9\u001b[39m     param_names = \u001b[38;5;28mlist\u001b[39m(inspect.signature(func).parameters.keys())[\u001b[32m1\u001b[39m:]  \u001b[38;5;66;03m# Skip self\u001b[39;00m\n\u001b[32m     10\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mTypeError\u001b[39;00m(\n\u001b[32m     11\u001b[39m         \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mfunc.\u001b[34m__name__\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m() requires keyword arguments. \u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m     12\u001b[39m         \u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33mPlease use \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mfunc.\u001b[34m__name__\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m(\u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[33m'\u001b[39m\u001b[33m, \u001b[39m\u001b[33m'\u001b[39m.join(\u001b[33mf\u001b[39m\u001b[33m'\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mname\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m=value\u001b[39m\u001b[33m'\u001b[39m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mfor\u001b[39;00m\u001b[38;5;250m \u001b[39mname\u001b[38;5;250m \u001b[39m\u001b[38;5;129;01min\u001b[39;00m\u001b[38;5;250m \u001b[39mparam_names)\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m)\u001b[39m\u001b[33m\"\u001b[39m\n\u001b[32m     13\u001b[39m     )\n\u001b[32m---> \u001b[39m\u001b[32m14\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mfunc\u001b[49m\u001b[43m(\u001b[49m\u001b[43m*\u001b[49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\db_control\\resources\\sync\\index.py:81\u001b[39m, in \u001b[36mIndexResource.create\u001b[39m\u001b[34m(self, name, spec, dimension, metric, timeout, deletion_protection, vector_type, tags)\u001b[39m\n\u001b[32m     59\u001b[39m \u001b[38;5;129m@require_kwargs\u001b[39m\n\u001b[32m     60\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mcreate\u001b[39m(\n\u001b[32m     61\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m   (...)\u001b[39m\u001b[32m     70\u001b[39m     tags: Optional[Dict[\u001b[38;5;28mstr\u001b[39m, \u001b[38;5;28mstr\u001b[39m]] = \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m     71\u001b[39m ) -> IndexModel:\n\u001b[32m     72\u001b[39m     req = PineconeDBControlRequestFactory.create_index_request(\n\u001b[32m     73\u001b[39m         name=name,\n\u001b[32m     74\u001b[39m         spec=spec,\n\u001b[32m   (...)\u001b[39m\u001b[32m     79\u001b[39m         tags=tags,\n\u001b[32m     80\u001b[39m     )\n\u001b[32m---> \u001b[39m\u001b[32m81\u001b[39m     resp = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m_index_api\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcreate_index\u001b[49m\u001b[43m(\u001b[49m\u001b[43mcreate_index_request\u001b[49m\u001b[43m=\u001b[49m\u001b[43mreq\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m     83\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m timeout == -\u001b[32m1\u001b[39m:\n\u001b[32m     84\u001b[39m         \u001b[38;5;28;01mreturn\u001b[39;00m IndexModel(resp)\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\endpoint.py:102\u001b[39m, in \u001b[36mEndpoint.__call__\u001b[39m\u001b[34m(self, *args, **kwargs)\u001b[39m\n\u001b[32m     91\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__call__\u001b[39m(\u001b[38;5;28mself\u001b[39m, *args, **kwargs):\n\u001b[32m     92\u001b[39m \u001b[38;5;250m    \u001b[39m\u001b[33;03m\"\"\"This method is invoked when endpoints are called\u001b[39;00m\n\u001b[32m     93\u001b[39m \u001b[33;03m    Example:\u001b[39;00m\n\u001b[32m     94\u001b[39m \n\u001b[32m   (...)\u001b[39m\u001b[32m    100\u001b[39m \n\u001b[32m    101\u001b[39m \u001b[33;03m    \"\"\"\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m102\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mcallable\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m*\u001b[49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\core\\openapi\\db_control\\api\\manage_indexes_api.py:322\u001b[39m, in \u001b[36mManageIndexesApi.__init__.<locals>.__create_index\u001b[39m\u001b[34m(self, create_index_request, **kwargs)\u001b[39m\n\u001b[32m    320\u001b[39m kwargs = \u001b[38;5;28mself\u001b[39m._process_openapi_kwargs(kwargs)\n\u001b[32m    321\u001b[39m kwargs[\u001b[33m\"\u001b[39m\u001b[33mcreate_index_request\u001b[39m\u001b[33m\"\u001b[39m] = create_index_request\n\u001b[32m--> \u001b[39m\u001b[32m322\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mcall_with_http_info\u001b[49m\u001b[43m(\u001b[49m\u001b[43m*\u001b[49m\u001b[43m*\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\endpoint.py:134\u001b[39m, in \u001b[36mEndpoint.call_with_http_info\u001b[39m\u001b[34m(self, **kwargs)\u001b[39m\n\u001b[32m    124\u001b[39m params = EndpointUtils.gather_params(\n\u001b[32m    125\u001b[39m     attribute_map=\u001b[38;5;28mself\u001b[39m.attribute_map,\n\u001b[32m    126\u001b[39m     location_map=\u001b[38;5;28mself\u001b[39m.location_map,\n\u001b[32m   (...)\u001b[39m\u001b[32m    129\u001b[39m     kwargs=kwargs,\n\u001b[32m    130\u001b[39m )\n\u001b[32m    132\u001b[39m HeaderUtil.prepare_headers(headers_map=\u001b[38;5;28mself\u001b[39m.headers_map, params=params)\n\u001b[32m--> \u001b[39m\u001b[32m134\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mapi_client\u001b[49m\u001b[43m.\u001b[49m\u001b[43mcall_api\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    135\u001b[39m \u001b[43m    \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43msettings\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mendpoint_path\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    136\u001b[39m \u001b[43m    \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43msettings\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mhttp_method\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    137\u001b[39m \u001b[43m    \u001b[49m\u001b[43mpath_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mpath\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    138\u001b[39m \u001b[43m    \u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mquery\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    139\u001b[39m \u001b[43m    \u001b[49m\u001b[43mheader_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mheader\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    140\u001b[39m \u001b[43m    \u001b[49m\u001b[43mbody\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mbody\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    141\u001b[39m \u001b[43m    \u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mform\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    142\u001b[39m \u001b[43m    \u001b[49m\u001b[43mfiles\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mfile\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    143\u001b[39m \u001b[43m    \u001b[49m\u001b[43mresponse_type\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43msettings\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mresponse_type\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    144\u001b[39m \u001b[43m    \u001b[49m\u001b[43mauth_settings\u001b[49m\u001b[43m=\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43msettings\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mauth\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    145\u001b[39m \u001b[43m    \u001b[49m\u001b[43masync_req\u001b[49m\u001b[43m=\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43masync_req\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    146\u001b[39m \u001b[43m    \u001b[49m\u001b[43masync_threadpool_executor\u001b[49m\u001b[43m=\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m.\u001b[49m\u001b[43mget\u001b[49m\u001b[43m(\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43masync_threadpool_executor\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mNone\u001b[39;49;00m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    147\u001b[39m \u001b[43m    \u001b[49m\u001b[43m_check_type\u001b[49m\u001b[43m=\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43m_check_return_type\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    148\u001b[39m \u001b[43m    \u001b[49m\u001b[43m_return_http_data_only\u001b[49m\u001b[43m=\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43m_return_http_data_only\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    149\u001b[39m \u001b[43m    \u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m=\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43m_preload_content\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    150\u001b[39m \u001b[43m    \u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43mkwargs\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43m_request_timeout\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    151\u001b[39m \u001b[43m    \u001b[49m\u001b[43m_host\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_host\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    152\u001b[39m \u001b[43m    \u001b[49m\u001b[43mcollection_formats\u001b[49m\u001b[43m=\u001b[49m\u001b[43mparams\u001b[49m\u001b[43m[\u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mcollection_format\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    153\u001b[39m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\api_client.py:306\u001b[39m, in \u001b[36mApiClient.call_api\u001b[39m\u001b[34m(self, resource_path, method, path_params, query_params, header_params, body, post_params, files, response_type, auth_settings, async_req, async_threadpool_executor, _return_http_data_only, collection_formats, _preload_content, _request_timeout, _host, _check_type)\u001b[39m\n\u001b[32m    285\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m.threadpool_executor.submit(\n\u001b[32m    286\u001b[39m         \u001b[38;5;28mself\u001b[39m.__call_api,\n\u001b[32m    287\u001b[39m         resource_path,\n\u001b[32m   (...)\u001b[39m\u001b[32m    302\u001b[39m         _check_type,\n\u001b[32m    303\u001b[39m     )\n\u001b[32m    305\u001b[39m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m async_req:\n\u001b[32m--> \u001b[39m\u001b[32m306\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m__call_api\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    307\u001b[39m \u001b[43m        \u001b[49m\u001b[43mresource_path\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    308\u001b[39m \u001b[43m        \u001b[49m\u001b[43mmethod\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    309\u001b[39m \u001b[43m        \u001b[49m\u001b[43mpath_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    310\u001b[39m \u001b[43m        \u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    311\u001b[39m \u001b[43m        \u001b[49m\u001b[43mheader_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    312\u001b[39m \u001b[43m        \u001b[49m\u001b[43mbody\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    313\u001b[39m \u001b[43m        \u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    314\u001b[39m \u001b[43m        \u001b[49m\u001b[43mfiles\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    315\u001b[39m \u001b[43m        \u001b[49m\u001b[43mresponse_type\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    316\u001b[39m \u001b[43m        \u001b[49m\u001b[43mauth_settings\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    317\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_return_http_data_only\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    318\u001b[39m \u001b[43m        \u001b[49m\u001b[43mcollection_formats\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    319\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    320\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    321\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_host\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    322\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_check_type\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    323\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    325\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m.pool.apply_async(\n\u001b[32m    326\u001b[39m     \u001b[38;5;28mself\u001b[39m.__call_api,\n\u001b[32m    327\u001b[39m     (\n\u001b[32m   (...)\u001b[39m\u001b[32m    344\u001b[39m     ),\n\u001b[32m    345\u001b[39m )\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\api_client.py:182\u001b[39m, in \u001b[36mApiClient.__call_api\u001b[39m\u001b[34m(self, resource_path, method, path_params, query_params, header_params, body, post_params, files, response_type, auth_settings, _return_http_data_only, collection_formats, _preload_content, _request_timeout, _host, _check_type)\u001b[39m\n\u001b[32m    180\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m PineconeApiException \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[32m    181\u001b[39m     e.body = e.body.decode(\u001b[33m\"\u001b[39m\u001b[33mutf-8\u001b[39m\u001b[33m\"\u001b[39m)\n\u001b[32m--> \u001b[39m\u001b[32m182\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m e\n\u001b[32m    184\u001b[39m \u001b[38;5;28mself\u001b[39m.last_response = response_data\n\u001b[32m    186\u001b[39m return_data = response_data\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\api_client.py:170\u001b[39m, in \u001b[36mApiClient.__call_api\u001b[39m\u001b[34m(self, resource_path, method, path_params, query_params, header_params, body, post_params, files, response_type, auth_settings, _return_http_data_only, collection_formats, _preload_content, _request_timeout, _host, _check_type)\u001b[39m\n\u001b[32m    161\u001b[39m url = build_request_url(\n\u001b[32m    162\u001b[39m     config=config,\n\u001b[32m    163\u001b[39m     processed_path_params=path_params_tuple,\n\u001b[32m    164\u001b[39m     resource_path=resource_path,\n\u001b[32m    165\u001b[39m     _host=_host,\n\u001b[32m    166\u001b[39m )\n\u001b[32m    168\u001b[39m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[32m    169\u001b[39m     \u001b[38;5;66;03m# perform request and return response\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m170\u001b[39m     response_data = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mrequest\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    171\u001b[39m \u001b[43m        \u001b[49m\u001b[43mmethod\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    172\u001b[39m \u001b[43m        \u001b[49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    173\u001b[39m \u001b[43m        \u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mprocessed_query_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    174\u001b[39m \u001b[43m        \u001b[49m\u001b[43mheaders\u001b[49m\u001b[43m=\u001b[49m\u001b[43mheaders_tuple\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    175\u001b[39m \u001b[43m        \u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mprocessed_post_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    176\u001b[39m \u001b[43m        \u001b[49m\u001b[43mbody\u001b[49m\u001b[43m=\u001b[49m\u001b[43mbody\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    177\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    178\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    179\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    180\u001b[39m \u001b[38;5;28;01mexcept\u001b[39;00m PineconeApiException \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[32m    181\u001b[39m     e.body = e.body.decode(\u001b[33m\"\u001b[39m\u001b[33mutf-8\u001b[39m\u001b[33m\"\u001b[39m)\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\api_client.py:386\u001b[39m, in \u001b[36mApiClient.request\u001b[39m\u001b[34m(self, method, url, query_params, headers, post_params, body, _preload_content, _request_timeout)\u001b[39m\n\u001b[32m    376\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m.rest_client.OPTIONS(\n\u001b[32m    377\u001b[39m         url,\n\u001b[32m    378\u001b[39m         query_params=query_params,\n\u001b[32m   (...)\u001b[39m\u001b[32m    383\u001b[39m         body=body,\n\u001b[32m    384\u001b[39m     )\n\u001b[32m    385\u001b[39m \u001b[38;5;28;01melif\u001b[39;00m method == \u001b[33m\"\u001b[39m\u001b[33mPOST\u001b[39m\u001b[33m\"\u001b[39m:\n\u001b[32m--> \u001b[39m\u001b[32m386\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mrest_client\u001b[49m\u001b[43m.\u001b[49m\u001b[43mPOST\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    387\u001b[39m \u001b[43m        \u001b[49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    388\u001b[39m \u001b[43m        \u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    389\u001b[39m \u001b[43m        \u001b[49m\u001b[43mheaders\u001b[49m\u001b[43m=\u001b[49m\u001b[43mheaders\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    390\u001b[39m \u001b[43m        \u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    391\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    392\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    393\u001b[39m \u001b[43m        \u001b[49m\u001b[43mbody\u001b[49m\u001b[43m=\u001b[49m\u001b[43mbody\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    394\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    395\u001b[39m \u001b[38;5;28;01melif\u001b[39;00m method == \u001b[33m\"\u001b[39m\u001b[33mPUT\u001b[39m\u001b[33m\"\u001b[39m:\n\u001b[32m    396\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m.rest_client.PUT(\n\u001b[32m    397\u001b[39m         url,\n\u001b[32m    398\u001b[39m         query_params=query_params,\n\u001b[32m   (...)\u001b[39m\u001b[32m    403\u001b[39m         body=body,\n\u001b[32m    404\u001b[39m     )\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\rest_utils.py:146\u001b[39m, in \u001b[36mRestClientInterface.POST\u001b[39m\u001b[34m(self, url, headers, query_params, post_params, body, _preload_content, _request_timeout)\u001b[39m\n\u001b[32m    136\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mPOST\u001b[39m(\n\u001b[32m    137\u001b[39m     \u001b[38;5;28mself\u001b[39m,\n\u001b[32m    138\u001b[39m     url,\n\u001b[32m   (...)\u001b[39m\u001b[32m    144\u001b[39m     _request_timeout=\u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[32m    145\u001b[39m ):\n\u001b[32m--> \u001b[39m\u001b[32m146\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43mrequest\u001b[49m\u001b[43m(\u001b[49m\n\u001b[32m    147\u001b[39m \u001b[43m        \u001b[49m\u001b[33;43m\"\u001b[39;49m\u001b[33;43mPOST\u001b[39;49m\u001b[33;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[32m    148\u001b[39m \u001b[43m        \u001b[49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    149\u001b[39m \u001b[43m        \u001b[49m\u001b[43mheaders\u001b[49m\u001b[43m=\u001b[49m\u001b[43mheaders\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    150\u001b[39m \u001b[43m        \u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mquery_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    151\u001b[39m \u001b[43m        \u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m=\u001b[49m\u001b[43mpost_params\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    152\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_preload_content\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    153\u001b[39m \u001b[43m        \u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m=\u001b[49m\u001b[43m_request_timeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    154\u001b[39m \u001b[43m        \u001b[49m\u001b[43mbody\u001b[49m\u001b[43m=\u001b[49m\u001b[43mbody\u001b[49m\u001b[43m,\u001b[49m\n\u001b[32m    155\u001b[39m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\rest_urllib3.py:267\u001b[39m, in \u001b[36mUrllib3RestClient.request\u001b[39m\u001b[34m(self, method, url, query_params, headers, body, post_params, _preload_content, _request_timeout)\u001b[39m\n\u001b[32m    264\u001b[39m     \u001b[38;5;66;03m# log response body\u001b[39;00m\n\u001b[32m    265\u001b[39m     logger.debug(\u001b[33m\"\u001b[39m\u001b[33mresponse body: \u001b[39m\u001b[38;5;132;01m%s\u001b[39;00m\u001b[33m\"\u001b[39m, r.data)\n\u001b[32m--> \u001b[39m\u001b[32m267\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mraise_exceptions_or_return\u001b[49m\u001b[43m(\u001b[49m\u001b[43mr\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\openapi_support\\rest_utils.py:49\u001b[39m, in \u001b[36mraise_exceptions_or_return\u001b[39m\u001b[34m(r)\u001b[39m\n\u001b[32m     46\u001b[39m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[32m500\u001b[39m <= r.status <= \u001b[32m599\u001b[39m:\n\u001b[32m     47\u001b[39m         \u001b[38;5;28;01mraise\u001b[39;00m ServiceException(http_resp=r)\n\u001b[32m---> \u001b[39m\u001b[32m49\u001b[39m     \u001b[38;5;28;01mraise\u001b[39;00m PineconeApiException(http_resp=r)\n\u001b[32m     51\u001b[39m \u001b[38;5;28;01mreturn\u001b[39;00m r\n",
      "\u001b[31mPineconeApiException\u001b[39m: (400)\nReason: Bad Request\nHTTP response headers: HTTPHeaderDict({'content-type': 'text/plain; charset=utf-8', 'access-control-allow-origin': '*', 'vary': 'origin,access-control-request-method,access-control-request-headers', 'access-control-expose-headers': '*', 'x-pinecone-api-version': '2025-04', 'x-cloud-trace-context': '34e4dab27605130dd896766e1bc5504b', 'date': 'Thu, 13 Nov 2025 02:17:41 GMT', 'server': 'Google Frontend', 'Content-Length': '125', 'Via': '1.1 google', 'Alt-Svc': 'h3=\":443\"; ma=2592000,h3-29=\":443\"; ma=2592000'})\nHTTP response body: {\"error\":{\"code\":\"INVALID_ARGUMENT\",\"message\":\"Name must consist of lower case alphanumeric characters or '-'\"},\"status\":400}\n"
     ]
    }
   ],
   "source": [
    "from pinecone import ServerlessSpec\n",
    "\n",
    "index=\"medi_bot\"\n",
    "if not pc.has_index(index):\n",
    "    pc.create_index(\n",
    "        name=index,\n",
    "        dimension=384,\n",
    "        metric= \"cosine\" ,#cosine  similarity,\n",
    "        spec=ServerlessSpec(cloud=\"aws\",region=\"us-east-1\") #specification\n",
    "    )\n",
    "index=pc.index(index)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "03fc84fa",
   "metadata": {},
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "'Pinecone' object has no attribute 'index'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mAttributeError\u001b[39m                            Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[12]\u001b[39m\u001b[32m, line 1\u001b[39m\n\u001b[32m----> \u001b[39m\u001b[32m1\u001b[39m index=\u001b[43mpc\u001b[49m\u001b[43m.\u001b[49m\u001b[43mindex\u001b[49m(name)\n",
      "\u001b[36mFile \u001b[39m\u001b[32mc:\\Users\\Manodya\\Desktop\\Bsc.AI\\PROJECTS\\Medical chatbot\\Medical-chat-bot\\medibot\\Lib\\site-packages\\pinecone\\utils\\plugin_aware.py:106\u001b[39m, in \u001b[36mPluginAware.__getattr__\u001b[39m\u001b[34m(self, name)\u001b[39m\n\u001b[32m    102\u001b[39m     \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mAttributeError\u001b[39;00m:\n\u001b[32m    103\u001b[39m         \u001b[38;5;66;03m# If we can't get the required attributes, we can't load plugins\u001b[39;00m\n\u001b[32m    104\u001b[39m         \u001b[38;5;28;01mpass\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m106\u001b[39m \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mAttributeError\u001b[39;00m(\u001b[33mf\u001b[39m\u001b[33m\"\u001b[39m\u001b[33m'\u001b[39m\u001b[38;5;132;01m{\u001b[39;00m\u001b[38;5;28mself\u001b[39m.\u001b[34m__class__\u001b[39m.\u001b[34m__name__\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m'\u001b[39m\u001b[33m object has no attribute \u001b[39m\u001b[33m'\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mname\u001b[38;5;132;01m}\u001b[39;00m\u001b[33m'\u001b[39m\u001b[33m\"\u001b[39m)\n",
      "\u001b[31mAttributeError\u001b[39m: 'Pinecone' object has no attribute 'index'"
     ]
    }
   ],
   "source": [
    "index=pc.index(name)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "medibot (3.12.0)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
